1
|
Sánchez A, Galan-Caamal RJ, Ortiz-Hernández MC, Sánchez-Sánchez J, Camacho-Cruz KA, Anguas-Cabrera D. Ammonium depletion associated with the COVID-19 pandemic in the Mexican Caribbean. Mar Pollut Bull 2024; 202:116347. [PMID: 38608428 DOI: 10.1016/j.marpolbul.2024.116347] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/25/2024] [Revised: 04/03/2024] [Accepted: 04/04/2024] [Indexed: 04/14/2024]
Abstract
The Mexican Caribbean contributes significantly to Mexico's gross national product. The number of tourists declined from 16.7 million in 2019 to 8.8 million in 2020 due to the COVID-19 pandemic, with a rapid recovery of 13.5 million in 2021. Wastewater discharge is the primary contamination source associated with the tourism sector's demand for goods and services. Water quality could improve due to fewer tourists arriving during the COVID-19 sanitary emergency. This study aimed to quantify ammonium concentrations at eleven locations to evaluate water quality during the sanitary restriction due to the pandemic in the Mexican Caribbean. The ammonium concentrations were 85 % (Nov-2019), 89 % (Feb-2020), and 86 % (Feb-2021) higher than in Nov-2020, where six of the eleven sampled stations were below the detection limit (0.15 μM). Lower ammonium concentrations coincide with the sanitary restriction period and a decrease in affluent tourists.
Collapse
Affiliation(s)
- A Sánchez
- Centro Interdisciplinario de Ciencias Marinas del Instituto Politécnico Nacional, La Paz, B.C.S., Mexico.
| | - R J Galan-Caamal
- El Colegio de la Frontera Sur, Unidad Chetumal, Chetumal, Quintana Roo, Mexico
| | | | - J Sánchez-Sánchez
- El Colegio de la Frontera Sur, Unidad Chetumal, Chetumal, Quintana Roo, Mexico
| | - K A Camacho-Cruz
- Centro Interdisciplinario de Ciencias Marinas del Instituto Politécnico Nacional, La Paz, B.C.S., Mexico; Instituto de Ciencias del Mar y Limnología, Universidad Nacional Autónoma de México, Puerto Morelos, Quintana Roo, Mexico
| | - D Anguas-Cabrera
- El Colegio de la Frontera Sur, Unidad Chetumal, Chetumal, Quintana Roo, Mexico
| |
Collapse
|
2
|
Peraire J, García-Pardo G, Chafino S, Sánchez A, Botero-Gallego M, Olona M, Espineira S, Reverté L, Skouridou V, Peiró ÓM, Gómez-Bertomeu F, Vidal F, O' Sullivan CK, Rull A. Immunoglobulins in COVID-19 pneumonia: from the acute phase to the recovery phase. Eur J Med Res 2024; 29:223. [PMID: 38581072 PMCID: PMC10998353 DOI: 10.1186/s40001-024-01824-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 03/31/2024] [Indexed: 04/07/2024] Open
Abstract
BACKGROUND COVID-19 pneumonia causes hyperinflammatory response that culminates in acute respiratory syndrome (ARDS) related to increased multiorgan dysfunction and mortality risk. Antiviral-neutralizing immunoglobulins production reflect the host humoral status and illness severity, and thus, immunoglobulin (Ig) circulating levels could be evidence of COVID-19 prognosis. METHODS The relationship among circulating immunoglobulins (IgA, IgG, IgM) and COVID-19 pneumonia was evaluated using clinical information and blood samples in a COVID-19 cohort composed by 320 individuals recruited during the acute phase and followed up to 4 to 8 weeks (n = 252) from the Spanish first to fourth waves. RESULTS COVID-19 pneumonia development depended on baseline Ig concentrations. Circulating IgA levels together with clinical features at acute phase was highly associated with COVID-19 pneumonia development. IgM was positively correlated with obesity (ρb = 0.156, P = 0.020), dyslipemia (ρb = 0.140, P = 0.029), COPD (ρb = 0.133, P = 0.037), cancer (ρb = 0.173, P = 0.007) and hypertension (ρb = 0.148, P = 0.020). Ig concentrations at recovery phase were related to COVID-19 treatments. CONCLUSIONS Our results provide valuable information on the dynamics of immunoglobulins upon SARS-CoV-2 infection or other similar viruses.
Collapse
Affiliation(s)
- Joaquim Peraire
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Graciano García-Pardo
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Silvia Chafino
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Alba Sánchez
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
| | - Maryluz Botero-Gallego
- Universitat Rovira I Virgili (URV), Tarragona, Spain
- INTERFIBIO Consolidated Research Group, Tarragona, Spain
| | - Montserrat Olona
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Sonia Espineira
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Laia Reverté
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
| | - Vasso Skouridou
- Universitat Rovira I Virgili (URV), Tarragona, Spain
- INTERFIBIO Consolidated Research Group, Tarragona, Spain
| | - Óscar M Peiró
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Fréderic Gómez-Bertomeu
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Francesc Vidal
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira I Virgili (URV), Tarragona, Spain
| | - Ciara K O' Sullivan
- Universitat Rovira I Virgili (URV), Tarragona, Spain.
- INTERFIBIO Consolidated Research Group, Tarragona, Spain.
| | - Anna Rull
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain.
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
- Universitat Rovira I Virgili (URV), Tarragona, Spain.
| |
Collapse
|
3
|
Passols M, Llobet-Cabau F, Sebastià C, Castelló A, Valdés-Hernández J, Criado-Mesas L, Sánchez A, Folch JM. Identification of genomic regions, genetic variants and gene networks regulating candidate genes for lipid metabolism in pig muscle. Animal 2023; 17:101033. [PMID: 38064855 DOI: 10.1016/j.animal.2023.101033] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Revised: 11/03/2023] [Accepted: 11/06/2023] [Indexed: 12/23/2023] Open
Abstract
The intramuscular fat content and fatty acid composition of porcine meat have a significant impact on its quality and nutritional value. This research aimed to investigate the expression of 45 genes involved in lipid metabolism in the longissimus dorsi muscle of three experimental pig backcrosses, with a 25% of Iberian background. To achieve this objective, we conducted an expression Genome-Wide Association Study (eGWAS) using gene expression levels in muscle measured by high-throughput real-time qPCR for 45 target genes and genotypes from the PorcineSNP60 BeadChip or Axiom Porcine Genotyping Array and 65 single nucleotide polymorphisms (SNPs) located in 20 genes genotyped by a custom-designed Taqman OpenArray in a cohort of 354 animals. The eGWAS analysis identified 301 eSNPs associated with 18 candidate genes (ANK2, APOE, ARNT, CIITA, CPT1A, EGF, ELOVL6, ELOVL7, FADS3, FASN, GPAT3, NR1D2, NR1H2, PLIN1, PPAP2A, RORA, RXRA and UCP3). Three cis-eQTL (expression quantitative trait loci) were identified for GPAT3, RXRA, and UCP3 genes, which indicates that a genetic polymorphism proximal to the same gene is affecting its expression. Furthermore, 24 trans-eQTLs were detected, and eight candidate regulatory genes were located in these genomic regions. Additionally, two trans-regulatory hotspots in Sus scrofa chromosomes 13 and 15 were identified. Moreover, a co-expression analysis performed on 89 candidate genes and the fatty acid composition revealed the regulatory role of four genes (FABP5, PPARG, SCD, and SREBF1). These genes modulate the levels of α-linolenic, arachidonic, and oleic acids, as well as regulating the expression of other candidate genes associated with lipid metabolism. The findings of this study offer novel insights into the functional regulatory mechanism of genes involved in lipid metabolism, thereby enhancing our understanding of this complex biological process.
Collapse
Affiliation(s)
- M Passols
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España.
| | - F Llobet-Cabau
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| | - C Sebastià
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| | - A Castelló
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| | - J Valdés-Hernández
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| | - L Criado-Mesas
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España
| | - A Sánchez
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| | - J M Folch
- Plant and Animal Genomics, Centre for Research in Agrigenomics (CRAG), CSIC-IRTA-UAB-UB, Campus UAB, Bellaterra, España; Departament de Ciència Animal i dels Aliments, Facultat de Veterinària, Universitat Autònoma de Barcelona (UAB), Bellaterra, España
| |
Collapse
|
4
|
Sánchez A, García-Pardo G, Gómez-Bertomeu F, López-Dupla M, Foguet-Romero E, Buzón MJ, Almirante B, Olona M, Fernández-Veledo S, Vidal F, Chafino S, Rull A, Peraire J. Mitochondrial dysfunction, lipids metabolism, and amino acid biosynthesis are key pathways for COVID-19 recovery. iScience 2023; 26:107948. [PMID: 37810253 PMCID: PMC10551651 DOI: 10.1016/j.isci.2023.107948] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Revised: 08/29/2023] [Accepted: 09/14/2023] [Indexed: 10/10/2023] Open
Abstract
The metabolic alterations caused by SARS-CoV-2 infection reflect disease progression. To analyze molecules involved in these metabolic changes, a multiomics study was performed using plasma from 103 patients with different degrees of COVID-19 severity during the evolution of the infection. With the increased severity of COVID-19, changes in circulating proteomic, metabolomic, and lipidomic profiles increased. Notably, the group of severe and critical patients with high HRG and ChoE (20:3) and low alpha-ketoglutaric acid levels had a high chance of unfavorable disease evolution (AUC = 0.925). Consequently, patients with the worst prognosis presented alterations in the TCA cycle (mitochondrial dysfunction), lipid metabolism, amino acid biosynthesis, and coagulation. Our findings increase knowledge regarding how SARS-CoV-2 infection affects different metabolic pathways and help in understanding the future consequences of COVID-19 to identify potential therapeutic targets.
Collapse
Affiliation(s)
- Alba Sánchez
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
| | - Graciano García-Pardo
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Fréderic Gómez-Bertomeu
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Miguel López-Dupla
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Elisabet Foguet-Romero
- Eurecat, Centre Tecnologic de Catalunya, Centre for Omic Sciences (Joint Unit Eurecat - Universitat Rovira i Virgili), Unique Scientific and Technical Infrastructure (ICTS), Reus, Spain
| | - Maria José Buzón
- Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Infectious Diseases Department, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, (VHIR) Task Force COVID-19, Barcelona, Spain
| | - Benito Almirante
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
| | - Montserrat Olona
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Sonia Fernández-Veledo
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| | - Francesc Vidal
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Silvia Chafino
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
| | - Anna Rull
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - Joaquim Peraire
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
| | - for the COVIDOMICS Study Group
- Institut Investigació Sanitària Pere Virgili (IISPV), Tarragona, Spain
- Hospital Universitari de Tarragona Joan XXIII (HJ23), Tarragona, Spain
- Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain
- Universitat Rovira i Virgili (URV), Tarragona, Spain
- Eurecat, Centre Tecnologic de Catalunya, Centre for Omic Sciences (Joint Unit Eurecat - Universitat Rovira i Virgili), Unique Scientific and Technical Infrastructure (ICTS), Reus, Spain
- Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Infectious Diseases Department, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, (VHIR) Task Force COVID-19, Barcelona, Spain
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain
| |
Collapse
|
5
|
Oviedo-Ocaña ER, Abendroth C, Domínguez IC, Sánchez A, Dornack C. Life cycle assessment of biowaste and green waste composting systems: A review of applications and implementation challenges. Waste Manag 2023; 171:350-364. [PMID: 37708800 DOI: 10.1016/j.wasman.2023.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 08/21/2023] [Accepted: 09/04/2023] [Indexed: 09/16/2023]
Abstract
Composting is one of the most widely applied methods for recycling organic waste. This process has been proposed as one option that facilitates the reincorporation of materials into the production cycle. However, composting also generates environmental impacts. Life Cycle Assessment (LCA) is the most common approach to evaluate the environmental impacts of a process at different system stages. Nevertheless, applying LCA in composting facilities is challenging due to the extensive information required, the lack of standardization on the initial assumptions, the definition of system boundaries, and the high diversity of existing composting technologies. This paper systematically reviews LCA studies in biowaste and/or green waste composting. The study highlights the challenges that should be met in order to improving the application of LCA to evaluate the environmental impacts of this type or waste treatment strategy. The review protocol used identified 456 papers published between 2010 and 2022. After the screening, 56 papers were selected, read, and thoroughly analyzed. The results show that: i) about 68% of the studies aimed to compare composting with other solid waste management options; ii) there was a wide diversity among the impact categories considered, which predominantly included climate change and ozone depletion; iii) there was no consensus on the functional unit or the system boundaries; iv) the main gaseous emissions studied were ammonia, methane, and nitrogen oxide, which were generally determined by emission factors; v) the avoided environmental impacts associated with the end-product quality and its application as an organic amendment or soil improver were ignored. This work demonstrates the complexity of conducting credible and valid composting LCA studies and proposes seven recommendations for improving the application of this assessment methodology to analyze this waste management alternative.
Collapse
Affiliation(s)
- E R Oviedo-Ocaña
- Universidad Industrial de Santander, Facultad de Ingenierías Fisicomecánicas, Grupo de Investigación en Recurso Hídrico y Saneamiento Ambiental - GPH, Carrera 27 Calle 9 Ciudad Universitaria Bucaramanga, Colombia
| | - C Abendroth
- Technische Universität Dresden, Institute of Waste Management and Circular Economy, Pratzschwitzer Str. 15. 01796 Pirna, Germany; Brandenburg Technical University Cottbus-Senftenberg, Faculty of Environment and Natural Sciences, Lehrgebäude 4 A R2.25, Siemens-Halske-Ring 8 03046 Cottbus, Germany
| | - I C Domínguez
- Universidad Industrial de Santander, Facultad de Ingenierías Fisicomecánicas, Grupo de Investigación en Recurso Hídrico y Saneamiento Ambiental - GPH, Carrera 27 Calle 9 Ciudad Universitaria Bucaramanga, Colombia
| | - A Sánchez
- Universitat Autònoma de Barcelona, Department of Chemical Engineering, Composting Research Group, 08193, Barcelona, Bellaterra, Spain.
| | - C Dornack
- Technische Universität Dresden, Institute of Waste Management and Circular Economy, Pratzschwitzer Str. 15. 01796 Pirna, Germany
| |
Collapse
|
6
|
Serradilla J, Andrés Moreno AM, Talayero P, Burgos P, Machuca M, Camps Ortega O, Vallejo MT, Rubio Bolívar FJ, Bueno A, Sánchez A, Zambrano C, De la Torre Ramos CA, Rodríguez O, Largo C, Serrano P, Prieto Bozano G, Ramos E, López Santamaría M, Stringa P, Hernández F. Preclinical Study of DCD and Normothermic Perfusion for Visceral Transplantation. Transpl Int 2023; 36:11518. [PMID: 37745640 PMCID: PMC10514355 DOI: 10.3389/ti.2023.11518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2023] [Accepted: 08/25/2023] [Indexed: 09/26/2023]
Abstract
Considering recent clinical and experimental evidence, expectations for using DCD-derived intestines have increased considerably. However, more knowledge about DCD procedure and long-term results after intestinal transplantation (ITx) is needed. We aimed to describe in detail a DCD procedure for ITx using normothermic regional perfusion (NRP) in a preclinical model. Small bowel was obtained from pigs donors after 1 h of NRP and transplanted to the recipients. Graft Intestinal samples were obtained during the procedure and after transplantation. Ischemia-reperfusion injury (Park-Chiu score), graft rejection and transplanted intestines absorptive function were evaluated. Seven of 8 DCD procedures with NRP and ITx were successful (87.5%), with a good graft reperfusion and an excellent recovery of the recipient. The architecture of grafts was well conserved during NRP. After an initial damage of Park-chiu score of 4, all grafts recovered from ischemia-reperfusion, with no or very subtle alterations 2 days after ITx. Most recipients (71.5%) did not show signs of rejection. Only two cases demonstrated histologic signs of mild rejection 7 days after ITx. Interestingly intestinal grafts showed good absorptive capacity. The study's results support the viability of intestinal grafts from DCD using NRP, contributing more evidence for the use of DCD for ITx.
Collapse
Affiliation(s)
- Javier Serradilla
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Ane Miren Andrés Moreno
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Paloma Talayero
- Department of Immunology, University Hospital 12 de Octubre, Madrid, Spain
| | - Paula Burgos
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
- Department of Cardiovascular Surgery, La Paz University Hospital, Madrid, Spain
| | - Mariana Machuca
- Special Pathology Laboratory, Faculty of Veterinary Sciences, National University of La Plata, La Plata, Argentina
| | - Onys Camps Ortega
- Molecular Imaging and Immunohistochemistry Laboratory, Institute for Health Research IdiPaz, Madrid, Spain
| | - María Teresa Vallejo
- Molecular Imaging and Immunohistochemistry Laboratory, Institute for Health Research IdiPaz, Madrid, Spain
| | | | - Alba Bueno
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Alba Sánchez
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Cristina Zambrano
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
| | - Carlos Andrés De la Torre Ramos
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Olaia Rodríguez
- Department of Biochemistry, La Paz University Hospital, IdiPaz, Madrid, Spain
| | - Carlota Largo
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
- Department of Experimental Surgery, La Paz University Hospital, Madrid, Spain
| | - Pilar Serrano
- Intestinal Rehabilitation and Transplantation Unit, La Paz University Hospital, Madrid, Spain
| | - Gerardo Prieto Bozano
- Intestinal Rehabilitation and Transplantation Unit, La Paz University Hospital, Madrid, Spain
| | - Esther Ramos
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
- Intestinal Rehabilitation and Transplantation Unit, La Paz University Hospital, Madrid, Spain
| | - Manuel López Santamaría
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| | - Pablo Stringa
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
- Institute for Immunological and Pathophysiological Studies (IIFP), National University of La Plata, National Council of Scientific and Technical Research (CONICET), La Plata, Argentina
| | - Francisco Hernández
- Department of Pediatric Surgery, La Paz University Hospital, Madrid, Spain
- Transplant Research Group, Institute for Health Research IdiPaz, Madrid, Spain
| |
Collapse
|
7
|
Caldarelli G, Arcaute E, Barthelemy M, Batty M, Gershenson C, Helbing D, Mancuso S, Moreno Y, Ramasco JJ, Rozenblat C, Sánchez A, Fernández-Villacañas JL. The role of complexity for digital twins of cities. Nat Comput Sci 2023; 3:374-381. [PMID: 38177836 DOI: 10.1038/s43588-023-00431-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/19/2021] [Accepted: 03/13/2023] [Indexed: 01/06/2024]
Abstract
We argue that theories and methods drawn from complexity science are urgently needed to guide the development and use of digital twins for cities. The theoretical framework from complexity science takes into account both the short-term and the long-term dynamics of cities and their interactions. This is the foundation for a new approach that treats cities not as large machines or logistic systems but as mutually interwoven self-organizing phenomena, which evolve, to an extent, like living systems.
Collapse
Affiliation(s)
- G Caldarelli
- DSMN University of Venice Ca'Foscari, Venice, Italy.
- ISC-CNR, Dipartimento di Fisica, Università Sapienza, Rome, Italy.
- London Institute for Mathematical Sciences, London, UK.
- Fondazione per il futuro delle città, Florence, Italy.
| | - E Arcaute
- CASA,The Bartlett Centre for Advanced Spatial Analysis, UCL, London, UK
- The Alan Turing Institute, The British Library, London, UK
| | - M Barthelemy
- Université Paris-Saclay, CNRS, CEA, Institut de Physique Théorique, Gif-sur-Yvette, France
- Centre d'Analyse et de Mathématique Sociales CAMS, UMR 8557 CNRS-EHESS, Ecole des Hautes Etudes en Sciences Sociales, Paris, France
| | - M Batty
- CASA,The Bartlett Centre for Advanced Spatial Analysis, UCL, London, UK
- The Alan Turing Institute, The British Library, London, UK
| | - C Gershenson
- Universidad Nacional Autónoma de México, Mexico City, Mexico
- Santa Fe Institute, Santa Fe, NM, USA
| | - D Helbing
- ETH Zurich, Computational Social Science, Zurich, Switzerland
- Complexity Science Hub, Vienna, Austria
| | - S Mancuso
- Fondazione per il futuro delle città, Florence, Italy
- Department of Agriculture, Food, Environment and Forestry (DAGRI), Florence, Italy
| | - Y Moreno
- Complexity Science Hub, Vienna, Austria
- Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Zaragoza, Spain
- Department of Theoretical Physics, Faculty of Sciences, University of Zaragoza, Zaragoza, Spain
- CENTAI Institute, Turin, Italy
| | - J J Ramasco
- Instituto de Física Interdisciplinar y Sistemas Complejos IFISC (CSIC-UIB), Palma de Mallorca, Spain
| | - C Rozenblat
- Institute of Geography and Sustainability, UNIL, Lausanne, Switzerland
| | - A Sánchez
- Institute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Zaragoza, Spain
- Grupo Interdisciplinar de Sistemas Complejos (GISC), Departamento de Matematicas, Universidad Carlos III de Madrid, Getafe, Spain
| | | |
Collapse
|
8
|
Mendez Carrascosa E, Vera E, Aldave D, Sánchez A, Velasco C, Castro Marcos E, Olmos D, Zapatero A, San José L, Romero Laorden N. 124P Feasibility of multidisciplinary translational CAPRICE project: Study protocol and workflow. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.09.125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
9
|
Rodriguez Hernandez A, Martinez Saez O, Brasó-Maristany F, Pastor B, Potrony M, Moreno L, Grau E, Puig-Butille J, Sánchez A, Schettini F, Conte B, Chic N, Vidal Losada M, Munoz M, Balaguer F, Prat A, Adamo B. 263P Clinical outcomes in patients with germline pathogenic variants in homologous recombination repair (HRR) genes treated with CDK4/6 inhibitors (CDK4/6i) and endocrine therapy (ET). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.302] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
10
|
Provencio-pulla M, Ortega A, Coves J, Franco F, Marsé R, Dómine M, Guirado M, Carcereny E, Fernández N, Martinez E, Blanco R, León L, Sánchez J, Sullivan I, Cobo M, Sánchez A, Massutí B. P1.15-09 First-line Atezolizumab plus Bevacizumab for Metastatic High-Intermediate TMB in Non-squamous NSCLC. The TELMA Study. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
11
|
Nadal E, Cantero A, Ortega A, Dómine M, Barba A, Blasco A, García J, Mosquera J, Vázquez S, Rodríguez D, López-Castro R, Juan-Vidal O, Sánchez A, Paz-Ares L, Hernández A, Iranzo P, Diz P, Provencio M, Simó M, Navarro V, Bruna J. EP08.01-029 NIVIPI-BRAIN, A Phase II Study of Nivolumab plus Ipilimumab Combined with Chemotherapy for Patients with NSCLC and Synchronous Brain Metastases. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.601] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
12
|
Martinez-Martin F, Corbella E, Sarasa I, Trias F, Petitbò D, Licerán M, Sánchez-Hernández R, Martin D, Sánchez A, Arnás C, de Dios S, Florido M, Pintó X. Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk. Semergen 2022; 48:403-410. [DOI: 10.1016/j.semerg.2022.04.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Revised: 03/31/2022] [Accepted: 04/15/2022] [Indexed: 11/29/2022]
|
13
|
Santos Bórnez MJ, Fernandez Castro M, Sanz J, Campos Esteban J, Godoy H, Merino Argumánez C, Rusinovich O, De la Torre Rubio N, Pavía Pascual M, Sánchez Fernández MC, Briongos Díaz PD, Garcia-Magallon B, Barbadillo Mateos C, De Villa LF, Isasi Zaragoza C, Andréu Sánchez JL, Sánchez A. AB0462 CORRELATION BETWEEN SAXON TEST AND UNSTIMULATED SALIVARY FLOW RATE IN PATIENTS WITH SUSPECTED SJÖGREN´S SYNDROME. Ann Rheum Dis 2022. [DOI: 10.1136/annrheumdis-2022-eular.1081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BackgroundSjögren syndrome (SS) is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of the exocrine glands, which alters their function producing dryness of the mouth, eyes and other mucous membranes. The method used to quantify glandular hypofunction is by whole saliva flow stimulated and unstimulated (UWSF) [1], which takes between 5 and 15 minutes (min). The Saxon test [2], is another tool with the same objective but requires less time: 2 minutes. In the literature, we only have found one study that compares the Saxon test with other diagnostic methods although it is developed in patients without SS [3].ObjectivesTo compare the Saxon test and UWSF in a cohort of patients with suspected SS.MethodsIn a consecutive cohort of patients who attended the rheumatology department for suspected SS, UWSF was measured (mL/5 min) and the Saxon test (gr/2 min) was performed. The Index Reported by Patients with Sjögren’s Syndrome of the EULAR (ESSPRI) was collected too. This is a patient-reported index designed to assess the severity of patients’ symptoms (dryness, pain, somatic and mental fatigue) in SS through an average of single 0–10 numerical scale for each domain. To measure the UWSF, patients were asked to swallow their saliva before the start of the test and then to spit into a container for 5 min. The Saxon test was performed by calculating the difference in the weight of two pieces of sterile gauze that the patient chews for two minutes. An UWSF >0.25 mL/min, a Saxon test >2.75 g/2min and an ESSPRI<5 were considered normal. Spearman’s rank correlation coefficient (rs) was used to determine the correlation between both quantitative variables. The Chi-square test and the Gamma test were used in the comparisons between the groups (altered and normal) and the Mann-Whitney U in the comparisons of the quantitative variables based on the groups (altered and normal) previously defined. P values <0.05 were considered statistically significant.ResultsWe enrolled 70 patients (63 women/7 men), with a mean age ± standard deviation of 54±13 years. The medians (Me) and interquartile ranges (IQR) obtained were 1.500 (0.6750 – 2.5000) mL/5min for the UWSF, 2.405 (1.6775-3.4925) g/2min for the Saxon test, 6.67 (3.67-7.67) for ESSPRI and 7.00 (4.00-8.00) for ESSPRI-dryness score.A direct and significant correlation between the Saxon test and the UWSF (rs=0.325; P=0.006) was observed. Twenty-four patients (34.3%) presented an altered UWSF and forty-two patients (60%) had an altered Saxon test. When we analysed the intensity of the association between the different groups (altered/normal) of both variables, we observed a direct and significant association (Gamma value=0.583, P=0.010) between both tools.We also detected differences in the Saxon test between patients with altered UWSF (Me: 1.89 gr/2min.; IQR: 1.47-2.68) and those with normal UWSF (Me: 2.78 gr/2 min.; IQR: 1.77-3, 75) (P=0.029). Similarly, we observed significant differences in UWSF values between patients with altered Saxon test (Me: 1.30 mL/5min IQR: 0.50-2.13) and those with a normal Saxon test (Me: 2.00 mL/5min IQR: 1.5-2.88) (P=0.008).Regarding the ESSPRI, 42 (62,7%) patients presented an altered ESSPRI and 49 (73,1%) had an altered ESSPRI-dryness score. The group patients with ESSPRI-dryness score≥5 obtained significantly worse scores on the Saxon test (Me: 2.10 g/2min IQR: 1.58-3.07) and on the ESSPRI (Me:7.33 IQR:5.83-8.00) than the normal ESSPRI-dryness score group: Me:3.02 g/2min, IQR:2.20-3.84, on Saxon test (P=0.026); Me: 2.66 IQR:1, 00-4.08, on the ESSPRI (P=0.000).ConclusionIn patients with suspected SS, there is a direct and significant correlation between the Saxon test and the UWSF. Therefore, the Saxon test could be useful in the initial assessment of oral gland dysfunction, to save time and/or to select patients who require performing the UWSF.References[1]Martínez Ceballos MA et al. Rev. Colomb Reumatol.2020; 27 (S2):90-101.[2]Kohler PF & Winter ME. Arthr & Rheum. 1985;28(10):1128-32.[3]Minagi HO et al. J Oral Rehabil.2020;47:1550-6.Disclosure of InterestsNone declared
Collapse
|
14
|
Viegas Madrid V, Peláez A, Sánchez A, Soriano J, Girón R. 581 UROLOGICAL SYMPTOMS IN PATIENTS WITH COVID-19: EXPLORING CHANGES IN FREQUENCY BY PANDEMIC WAVES. Continence 2022; 2:1-2. [PMID: 35822128 PMCID: PMC9263167 DOI: 10.1016/j.cont.2022.100470] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
15
|
Laguna Montes J, Pastor B, Moreno L, Albarran Artahona V, Potrony M, Sánchez A, Grau E, Gonzalez-Aguado L, Oriola J, Reyes R, Martínez D, Vinolas Segarra N, Gaba L, Adamo B, Reguart Aransay N, Puig-Butillé J, Teixido C, Mezquita L. 138P Prevalence and characteristics of lung cancer in families harboring pathogenic germline variants in cancer predisposing genes. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.02.168] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
|
16
|
Remon J, Bernabé R, Diz P, Felip E, González-Larriba JL, Lázaro M, Mielgo-Rubio X, Sánchez A, Sullivan I, Massutti B. SEOM-GECP-GETTHI Clinical Guidelines for the treatment of patients with thymic epithelial tumours (2021). Clin Transl Oncol 2022; 24:635-645. [PMID: 35122634 PMCID: PMC8817662 DOI: 10.1007/s12094-022-02788-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/20/2022] [Indexed: 11/27/2022]
Abstract
Thymic epithelial tumours (TET) represent a heterogeneous group of rare malignancies that include thymomas and thymic carcinoma. Treatment of TET is based on the resectability of the tumour. If this is considered achievable upfront, surgical resection is the cornerstone of treatment. Platinum-based chemotherapy is the standard regimen for advanced TET. Due to the rarity of this disease, treatment decisions should be discussed in specific multidisciplinary tumour boards, and there are few prospective clinical studies with new strategies. However, several pathways involved in TET have been explored as potential targets for new therapies in previously treated patients, such as multi-tyrosine kinase inhibitors with antiangiogenic properties and immune checkpoint inhibitors (ICI). One third of patient with thymoma present an autoimmune disorders, increasing the risk of immune-related adverse events and autoimmune flares under ICIs. In these guidelines, we summarize the current evidence for the therapeutic approach in patients with TET and define levels of evidence for these decisions.
Collapse
Affiliation(s)
- J Remon
- Department of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Nou Delfos, HM Hospitales, Avinguda de Vallcarca, 151, 08023, Barcelona, Spain.
| | - R Bernabé
- Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain
| | - P Diz
- Department of Medical Oncology, Hospital Universitario de León, León, Spain
| | - E Felip
- Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
| | - J L González-Larriba
- Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain
| | - M Lázaro
- Department of Medical Oncology, Hospital Alvaro Cunqueiro, Vigo, Spain
| | - X Mielgo-Rubio
- Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - A Sánchez
- Department of Medical Oncology, Consorcio Hospitalario Provincial de Castellón, Castellón de la Plana, Spain
| | - I Sullivan
- Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
| | - B Massutti
- Department of Medical Oncology, Hospital General Universitario de Alicante, Alicante, Spain
| |
Collapse
|
17
|
Deeken F, Sánchez A, Rapp MA, Denkinger M, Brefka S, Spank J, Bruns C, von Arnim CAF, Küster OC, Conzelmann LO, Metz BR, Maurer C, Skrobik Y, Forkavets O, Eschweiler GW, Thomas C. Outcomes of a Delirium Prevention Program in Older Persons After Elective Surgery: A Stepped-Wedge Cluster Randomized Clinical Trial. JAMA Surg 2022; 157:e216370. [PMID: 34910080 PMCID: PMC8674802 DOI: 10.1001/jamasurg.2021.6370] [Citation(s) in RCA: 39] [Impact Index Per Article: 19.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2021] [Accepted: 10/05/2021] [Indexed: 12/19/2022]
Abstract
Importance Delirium significantly worsens elective surgery outcomes and costs. Delirium risk is highest in elderly populations, whose surgical health care resource consumption (50%) exceeds their demographic proportion (15% to 18%) in high-resource countries. Effective nonpharmacologic delirium prevention could safely improve care in these vulnerable patients, but data from procedure-specific studies are insufficiently compelling to drive changes in practice. Delirium prevention approaches applicable to different surgical settings remain unexplored. Objective To examine whether a multifaceted prevention intervention is effective in reducing postoperative delirium incidence and prevalence after various major surgical procedures. Design, Setting, and Participants This stepped-wedge cluster randomized trial recruited 1470 patients 70 years and older undergoing elective orthopedic, general, or cardiac surgery from November 2017 to April 2019 from 5 German tertiary medical centers. Data were analyzed from December 2019 to July 2021. Interventions First, structured delirium education was provided to clinical caregivers at each site. Then, the study delirium prevention team assessed patient delirium risk factors and symptoms daily. Prevention was tailored to individual patient needs and could include: cognitive, motor, and sensory stimulation; meal companionship; accompaniment during diagnostic procedures; stress relaxation; and sleep promotion. Main Outcomes and Measures Postoperative delirium incidence and duration. Results Of 1470 included patients, 763 (51.9%) were male, and the median (IQR) age was 77 (74-81) years. Overall, the intervention reduced postoperative delirium incidence (odds ratio, 0.87; 95% CI, 0.77-0.98; P = .02) and percentage of days with delirium (intervention, 5.3%; control, 6.9%; P = .03). The effect was significant in patients undergoing orthopedic or abdominal surgery (odds ratio, 0.59; 95% CI, 0.35-0.99; P = .047) but not cardiac surgery (odds ratio, 1.18; 95% CI, 0.70-1.99; P = .54). Conclusions and Relevance This multifaceted multidisciplinary prevention intervention reduced postoperative delirium occurrence and days with delirium in older patients undergoing different elective surgical procedures but not cardiac procedures. These results suggest implementing this delirium prevention program will improve care and outcomes in older patients undergoing elective general and orthopedic procedures.
Collapse
Affiliation(s)
- Friederike Deeken
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| | - Alba Sánchez
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| | - Michael A. Rapp
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
- Social and Preventive Medicine, Department of Sports and Health Sciences, Intrafaculty Unit of Cognitive Sciences, Faculty of Human Science, and Faculty of Health Sciences Brandenburg, Research Area Services Research and e-Health, University of Potsdam, Potsdam, Germany
| | - Michael Denkinger
- Agaplesion Bethesda Clinic Ulm, Institute for Geriatric Research, Ulm University, Geriatric Center Ulm, Ulm, Germany
| | - Simone Brefka
- Agaplesion Bethesda Clinic Ulm, Institute for Geriatric Research, Ulm University, Geriatric Center Ulm, Ulm, Germany
- Department of Cardiothoracic and Vascular Surgery, Ulm University Hospital, Ulm, Germany
| | - Juliane Spank
- Department of Geriatric Psychiatry and Psychotherapy, Klinikum Stuttgart, Stuttgart, Germany
| | - Carola Bruns
- Department of Geriatric Psychiatry and Psychotherapy, Klinikum Stuttgart, Stuttgart, Germany
| | - Christine A. F. von Arnim
- Division of Geriatrics, University Medical Center Goettingen, Göttingen, Germany
- Department of Neurology, University Hospital Ulm, Ulm, Germany
| | | | | | - Brigitte R. Metz
- Geriatric Center Karlsruhe, ViDia Christian Clinics Karlsruhe, Karlsruhe, Germany
| | - Christoph Maurer
- Center for Geriatrics and Gerontology, Medical Center University of Freiburg, Freiburg, Germany
| | - Yoanna Skrobik
- Department of Medicine, McGill University, Montreal, Quebec, Canada
| | - Oksana Forkavets
- Department of Neurology, University Hospital Ulm, Ulm, Germany
- Geriatric Center at the University Hospital Tübingen, Tübingen, Germany
| | - Gerhard W. Eschweiler
- Geriatric Center at the University Hospital Tübingen, Tübingen, Germany
- Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany
| | - Christine Thomas
- Department of Geriatric Psychiatry and Psychotherapy, Klinikum Stuttgart, Stuttgart, Germany
- Department of Psychiatry and Psychotherapy, University Hospital of Tübingen, Tübingen, Germany
| |
Collapse
|
18
|
Villodre C, Taccogna L, Zapater P, Cantó M, Mena L, Ramia JM, Lluís F, Afonso N, Aguilella V, Aguiló J, Alados JC, Alberich M, Apio AB, Balongo R, Bra E, Bravo-Gutiérrez A, Briceño FJ, Cabañas J, Cánovas G, Caravaca I, Carbonell S, Carrera-Dacosta E, Castro EE, Caula C, Choolani-Bhojwani E, Codina A, Corral S, Cuenca C, Curbelo-Peña Y, Delgado-Morales MM, Delgado-Plasencia L, Doménech E, Estévez AM, Feria AM, Gascón-Domínguez MA, Gianchandani R, González C, Hevia RJ, González MA, Hidalgo JM, Lainez M, Lluís N, López F, López-Fernández J, López-Ruíz JA, Lora-Cumplido P, Madrazo Z, Marchena J, de la Cuadra MB, Martín S, Casas MI, Martínez P, Mena-Mateos A, Morales-García D, Mulas C, Muñoz-Forner E, Naranjo A, Navarro-Sánchez A, Oliver I, Ortega I, Ortega-Higueruelo R, Ortega-Ruiz S, Osorio J, Padín MH, Pamies JJ, Paredes M, Pareja-Ciuró F, Parra J, Pérez-Guarinós CV, Pérez-Saborido B, Pintor-Tortolero J, Plua-Muñiz K, Rey M, Rodríguez I, Ruiz C, Ruíz R, Ruiz S, Sánchez A, Sánchez D, Sánchez R, Sánchez-Cabezudo F, Sánchez-Santos R, Santos J, Serrano-Paz MP, Soria-Aledo V, Tallón-Aguilar L, Valdivia-Risco JH, Vallverdú-Cartié H, Varela C, Villar-Del-Moral J, Zambudio N. Simplified risk-prediction for benchmarking and quality improvement in emergency general surgery. Prospective, multicenter, observational cohort study. Int J Surg 2022; 97:106168. [PMID: 34785344 DOI: 10.1016/j.ijsu.2021.106168] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2021] [Revised: 10/24/2021] [Accepted: 11/03/2021] [Indexed: 02/07/2023]
Abstract
BACKGROUND AND AIMS Emergency General Surgery (EGS) conditions account for millions of deaths worldwide, yet it is practiced without benchmarking-based quality improvement programs. The aim of this observational, prospective, multicenter, nationwide study was to determine the best benchmark cutoff points in EGS, as a reference to guide improvement measures. METHODS Over a 6-month period, 38 centers (5% of all public hospitals) attending EGS patients on a 24-h, 7-days a week basis, enrolled consecutive patients requiring an emergent/urgent surgical procedure. Patients were stratified into cohorts of low (i.e., expected morbidity risk <33%), middle and high risk using the novel m-LUCENTUM calculator. RESULTS A total of 7258 patients were included; age (mean ± SD) was 51.1 ± 21.5 years, 43.2% were female. Benchmark cutoffs in the low-risk cohort (5639 patients, 77.7% of total) were: use of laparoscopy ≥40.9%, length of hospital stays ≤3 days, any complication within 30 days ≤ 17.7%, and 30-day mortality ≤1.1%. The variables with the greatest impact were septicemia on length of hospital stay (21 days; adjusted beta coefficient 16.8; 95% CI: 15.3 to 18.3; P < .001), and respiratory failure on mortality (risk-adjusted population attributable fraction 44.6%, 95% CI 29.6 to 59.6, P < .001). Use of laparoscopy (odds ratio 0.764, 95% CI 0.678 to 0.861; P < .001), and intraoperative blood loss (101-500 mL: odds ratio 2.699, 95% CI 2.152 to 3.380; P < .001; and 500-1000 mL: odds ratio 2.875, 95% CI 1.403 to 5.858; P = .013) were associated with increased morbidity. CONCLUSIONS This study offers, for the first time, clinically-based benchmark values in EGS and identifies measures for improvement.
Collapse
Affiliation(s)
- C Villodre
- Hospital Gran Canaria Doctor Negrín, Las Palmas de Gran Canarias, Spain Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain Hospital Lluís Alcanyís de Xàtiva, Valencia, Spain Hospital Universitario de Badajoz, Badajoz, Spain Hospital Universitario de Bellvitge, Barcelona, Spain Hospital Marina Baixa, Alicante, Spain Hospital Juan Ramón Jiménez, Infanta Elena, Huelva, Spain Hospital Infanta Cristina, Parla, Madrid, Spain Hospital Universitario de Canarias, Tenerife, Spain Hospital Reina Sofía de Córdoba, Córdoba, Spain H. Ramón y Cajal, Madrid, Spain Hospital Parc Taulí de Sabadell, Barcelona, Spain Hospital General Universitario de Alicante, Alicante, Spain Complejo Hospitalario Universitario de Vigo, Hospital Pontevedra, Spain Hospital Trueta de Girona, Girona, Spain Hospital Universitario Rio Hortega, Valladolid, Spain Hospital Mutua Terrassa, Barcelona, Spain Consorci Hospitalari de Vic, Barcelona, Spain POVISA, Pontevedra, Spain Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain Hospital Universitario Basurto, Bizkaia, Spain Hospital Universitario Marqués de Valdecilla, Santander, Spain Hospital de Viladecans, Barcelona, Spain Hospital Clínico de Valencia, Valencia, Spain Hospital Universitario Insular de Gran Canaria, Las Palmas, Spain Hospital Vírgen de la Macarena, Sevilla, Spain Hospital Cabueñes, Gijón, Spain Complejo Hospitalario de Jaén, Jaén, Spain Hospital Universitari Sant Joan de Reus, Tarragona, Spain Hospital Universitario Infanta Sofía, Madrid, Spain Complejo Hospitalario Torrecárdenas, Almería, Spain Hospital Sant Pau i Santa Tecla, Tarragona, Spain Hospital General Rafael Méndez de Lorca, Murcia, Spain Hospital Vírgen del Rocío, Sevilla, Spain Hospital Morales Meseguer, Murcia, Spain Hospital del Vinalopó, Alicante, Spain Hospital Universitario del Vinalopó, Alicante, Spain Hospital Universitario Virgen de las Nieves, Granada, Spain Department of Surgery, General University Hospital of Alicante, Alicante, Spain Department of Clinical Pharmacology, General University Hospital of Alicante, Alicante, Spain Computing, BomhardIP, Alicante, Spain Department of Clinical Documentation, General University Hospital of Alicante, Alicante, Spain Institute of Health and Biomedical Research of Alicante, ISABIAL, Alicante, Spain
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Bejarano M, Ramos C, Rosas E, Madera C, Rascón R, Balderas C, Cabrera Á, Rocha U, Fuchs V, Sánchez A, Bermeo E, Guzmán R, Álvarez K, Gallardo A, Hernández E, Sierra M, Acosta G. Risk factors and mortality rate in Covid-19 critically ill patients in Mexico. Clin Nutr ESPEN 2021. [PMCID: PMC8629548 DOI: 10.1016/j.clnesp.2021.09.446] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
20
|
Cortellini A, Roldán E, Garcia MC, Berardi R, Sánchez A, Martinez C, Parisi A, Jones E, Bertulli R, Rizzo G, Guida A, Chung C, Bower M, Betti M, Vincenzi B, Mirallas O, Biello F, Queirolo P, Gennari A, Pinato D. 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Ann Oncol 2021. [PMCID: PMC8454394 DOI: 10.1016/j.annonc.2021.08.1553] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
21
|
Company Calabuig AM, Nunez E, Sánchez A, Nicolaides KH, Charakida M, De Paco Matallana C. Three-dimensional echocardiography and cardiac strain imaging in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2021; 58:278-284. [PMID: 33949740 DOI: 10.1002/uog.23666] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/19/2021] [Revised: 04/15/2021] [Accepted: 04/21/2021] [Indexed: 06/12/2023]
Abstract
OBJECTIVES Gestational diabetes mellitus (GDM) is associated with premature cardiovascular disease and adverse cardiovascular outcome in the mother. Subclinical cardiac functional changes in the left ventricle have been reported during pregnancy in women with GDM using conventional echocardiography, but results are inconsistent. The aims of the current study were to assess whether GDM is associated with biventricular systolic dysfunction in the mother and whether these cardiac changes can be detected using the novel echocardiographic modalities of strain imaging and three-dimensional (3D) echocardiography. METHODS This was a cross-sectional study in women with GDM and controls examined at 26-40 weeks of gestation. All women underwent echocardiography, and 3D volumes of the left and right ventricles and left atrium were collected. Ejection fraction and left ventricular mass were measured using 3D echocardiography. Left ventricular mass was indexed to body surface area. Speckle-tracking echocardiography was used to assess global longitudinal strain of the left and right ventricles and strain of the left atrium. RESULTS The study population included 123 women with GDM and 246 controls. Women with GDM, compared to controls, were older (35.1 ± 5.2 vs 32.4 ± 5.5 years; P < 0.001), had higher body mass index (30.6 (interquartile range (IQR), 26.2-35.2) vs 27.5 (IQR, 24.7-30.7) kg/m2 ; P < 0.001) and had higher systolic blood pressure (119.9 ± 11.2 vs 116.4 ± 12.0 mmHg; P = 0.007). In all women with GDM, there was good glycemic control. In women with GDM, compared to controls, there was lower global longitudinal strain of the left ventricle (-19.3% (IQR, -21.4 to -17.6%) vs -20.1% (IQR, -22.1 to -18.7%); P = 0.002) and right ventricle (-22.2% (IQR, -26.1 to -19.8%) vs -24.1% (IQR, -27.0 to -21.9%); P < 0.001). There was no significant difference between the groups in ejection fraction, left ventricular mass, diastolic function assessed by left atrial strain, or 3D functional indices. CONCLUSIONS Women with GDM, compared to women with uncomplicated pregnancy, have lower left and right ventricular myocardial deformation. Volumetric assessment using 3D echocardiography does not provide additional information about maternal cardiac function. Strain imaging is a sensitive echocardiographic modality to detect early cardiac functional changes in women with GDM. Further studies are needed to assess the pattern of deterioration of cardiac function with advancing age in women with a history of GDM. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
Collapse
Affiliation(s)
- A M Company Calabuig
- Hospital Clínico Universitario Virgen de la Arrixaca and Institute for Biomedical Research of Murcia, IMIB-Arrixaca, Murcia, Spain
- Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK
| | - E Nunez
- Hospital Clínico Universitario Virgen de la Arrixaca and Institute for Biomedical Research of Murcia, IMIB-Arrixaca, Murcia, Spain
| | - A Sánchez
- Hospital Clínico Universitario Virgen de la Arrixaca and Institute for Biomedical Research of Murcia, IMIB-Arrixaca, Murcia, Spain
- Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK
| | - K H Nicolaides
- Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK
| | - M Charakida
- Harris Birthright Research Centre for Fetal Medicine, Fetal Medicine Research Institute, King's College Hospital, London, UK
- School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK
| | - C De Paco Matallana
- Hospital Clínico Universitario Virgen de la Arrixaca and Institute for Biomedical Research of Murcia, IMIB-Arrixaca, Murcia, Spain
| |
Collapse
|
22
|
Eschweiler GW, Czornik M, Herrmann ML, Knauer YP, Forkavets O, von Arnim CAF, Denkinger M, Küster O, Conzelmann L, Metz BR, Maurer C, Kentischer F, Deeken F, Sánchez A, Wagner S, Mennig E, Thomas C, Rapp MA. Presurgical Screening Improves Risk Prediction for Delirium in Elective Surgery of Older Patients: The PAWEL RISK Study. Front Aging Neurosci 2021; 13:679933. [PMID: 34385913 PMCID: PMC8353451 DOI: 10.3389/fnagi.2021.679933] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2021] [Accepted: 06/17/2021] [Indexed: 12/15/2022] Open
Abstract
Introduction: The number of elective surgeries for patients who are over 70 years of age is continuously growing. At the same time, postoperative delirium (POD) is common in older patients (5–60%) depending on predisposing risk factors, such as multimorbidity, cognitive impairment, neurodegenerative disorders and other dementing disorders, and precipitating factors, such as duration of surgery. Knowledge of individual risk profiles prior to elective surgery may help to identify patients at increased risk for development of POD. In this study, clinical and cognitive risk factors for POD were investigated in patients undergoing various elective cardiac and non-cardiac surgeries. Methods: The PAWEL study is a prospective, interventional trial on delirium prevention. At baseline, 880 inpatients at five surgical centers were recruited for sub-sample PAWEL-R. Multimodal assessments included clinical renal function, medication, American Society of Anesthesiologists (ASA) Physical Status Classification System, geriatric and cognitive assessments, which comprised the Montreal Cognitive Assessment Scale (MoCA), Trail-making Test, and Digit Span backward. Delirium incidence was monitored postoperatively by the Confusion Assessment Method (CAM) and a chart review for up to a week or until discharge. Multivariate regression models and Chi-square Automatic Interaction Detectors (CHAID) analyses were performed using delirium incidence as the primary outcome. Results: Eighteen risk factors were investigated in elective cardiovascular and orthopedic or general surgery. A total of 208 out of 880 patients (24%) developed POD. A global regression model that included all risk variables predicted delirium incidence with high accuracy (AUC = 0.81; 95% CI 0.77, 0.85). A simpler model (clinical and cognitive variables; model CLIN-COG) of 10 factors that only included surgery type, multimorbidity, renal failure, polypharmacy, ASA, cut-to-suture time, and cognition (MoCA, Digit Span backward, and preexisting dementia), however, exhibited similar predictive accuracy (AUC = 0.80; 95% CI 0.76, 0.84). Conclusion: The risk of developing POD can be estimated by preoperative assessments, such as ASA classification, expected cut-to-suture time, and short cognitive screenings. This rather efficient approach predicted POD risk over all types of surgery. Thus, a basic risk assessment including a cognitive screen can help to stratify patients at low, medium, or high POD risk to provide targeted prevention and/or management strategies for patients at risk.
Collapse
Affiliation(s)
- Gerhard W Eschweiler
- Geriatric Center, Department of Psychiatry and Psychotherapy, Tübingen University Hospital, Tübingen, Germany
| | - Manuel Czornik
- Geriatric Center, Department of Psychiatry and Psychotherapy, Tübingen University Hospital, Tübingen, Germany
| | - Matthias L Herrmann
- Geriatric Center, Department of Psychiatry and Psychotherapy, Tübingen University Hospital, Tübingen, Germany.,Department of Neurology and Neurophysiology, Medical Center-University of Freiburg, Freiburg, Germany
| | - Yvonne P Knauer
- Geriatric Center, Department of Psychiatry and Psychotherapy, Tübingen University Hospital, Tübingen, Germany
| | - Oksana Forkavets
- Geriatric Center, Department of Psychiatry and Psychotherapy, Tübingen University Hospital, Tübingen, Germany
| | - Christine A F von Arnim
- Department of Neurology, University Hospital of Ulm, Ulm, Germany.,Division of Geriatrics, University Medical Center Göttingen, Göttingen, Germany
| | - Michael Denkinger
- Institute for Geriatric Research, Agaplesion Bethesda Ulm and Ulm University, Ulm, Germany
| | - Olivia Küster
- Department of Neurology, University Hospital of Ulm, Ulm, Germany
| | | | - Brigitte R Metz
- Geriatric Center and Department of Geriatric Medicine, ViDia Christian Clinics Karlsruhe, Karlsruhe, Germany
| | - Christoph Maurer
- Department of Neurology and Neurophysiology, Medical Center-University of Freiburg, Freiburg, Germany
| | - Felix Kentischer
- Department of Neurology and Neurophysiology, Medical Center-University of Freiburg, Freiburg, Germany
| | - Friederike Deeken
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| | - Alba Sánchez
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| | - Sören Wagner
- Department of Anesthesiology, Klinikum Stuttgart, Stuttgart, Germany
| | - Eva Mennig
- Department of Geriatric Psychiatry and Psychotherapy, Klinikum Stuttgart, Stuttgart, Germany
| | - Christine Thomas
- Department of Geriatric Psychiatry and Psychotherapy, Klinikum Stuttgart, Stuttgart, Germany
| | - Michael A Rapp
- Department of Social and Preventive Medicine, University of Potsdam, Potsdam, Germany
| |
Collapse
|
23
|
Bayó C, Castellano G, Ocaña T, Moreira L, Carballal S, Sánchez A, Moreira R, Ortiz O, Castells A, Pellisé M, Juan-Otero M, Benitez-Ribas D, Balaguer F. SO-26 In-silico Lynch syndrome-related neoantigens prediction for a dendritic cell-based cancer prevention vaccine. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.05.050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
24
|
Maciel Cardoso F, Meloni S, Gracia-Lázaro C, Antonioni A, Cuesta JA, Sánchez A, Moreno Y. Framing in multiple public goods games and donation to charities. R Soc Open Sci 2021; 8:202117. [PMID: 34035947 PMCID: PMC8097214 DOI: 10.1098/rsos.202117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 11/24/2020] [Accepted: 03/31/2021] [Indexed: 06/12/2023]
Abstract
The vast amount of research devoted to public goods games has shown that contributions may be dramatically affected by varying framing conditions. This is particularly relevant in the context of donations to charities and non-governmental organizations. Here, we design a multiple public goods experiment by introducing five types of funds, each differing in the fraction of the contribution that is donated to a charity. We found that people contribute more to public goods when the associated social donations are presented as indirect rather than as direct donations. At the same time, the fraction of the donations devoted to charity is not affected by the framing. We have also found that, on average, women contribute to public goods and donate to charity significantly more than men. These findings are of potential interest to the design of social investment tools, in particular for charities to ask for better institutional designs from policy makers.
Collapse
Affiliation(s)
- F. Maciel Cardoso
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- Unidad Mixta Interdisciplinar de Comportamiento y Complejidad Social (UMICCS), Spain
| | - S. Meloni
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- IFISC, Institute for Cross-Disciplinary Physics and Complex Systems, Palma de Mallorca, Spain
| | - C. Gracia-Lázaro
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- Department of Theoretical Physics, Faculty of Sciences, Universidad de Zaragoza, Zaragoza, Spain
- Unidad Mixta Interdisciplinar de Comportamiento y Complejidad Social (UMICCS), Spain
| | - A. Antonioni
- Interdisciplinary Group of Complex Systems (GISC), Department of Mathematics, Universidad Carlos III de Madrid, Spain
| | - J. A. Cuesta
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- Unidad Mixta Interdisciplinar de Comportamiento y Complejidad Social (UMICCS), Spain
- Interdisciplinary Group of Complex Systems (GISC), Department of Mathematics, Universidad Carlos III de Madrid, Spain
- UC3M Santander Institute of Big Data (IBiDat), Universidad Carlos III de Madrid, Leganés, Spain
| | - A. Sánchez
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- Unidad Mixta Interdisciplinar de Comportamiento y Complejidad Social (UMICCS), Spain
- Interdisciplinary Group of Complex Systems (GISC), Department of Mathematics, Universidad Carlos III de Madrid, Spain
- UC3M Santander Institute of Big Data (IBiDat), Universidad Carlos III de Madrid, Leganés, Spain
| | - Y. Moreno
- Institute for Biocomputation and Physics of Complex Systems, Universidad de Zaragoza, Zaragoza, Spain
- Department of Theoretical Physics, Faculty of Sciences, Universidad de Zaragoza, Zaragoza, Spain
- Unidad Mixta Interdisciplinar de Comportamiento y Complejidad Social (UMICCS), Spain
- ISI Foundation, Turin, Italy
| |
Collapse
|
25
|
Guerra-Gorostegi N, González D, Puyuelo B, Ovejero J, Colón J, Gabriel D, Sánchez A, Ponsá S. Biomass fuel production from cellulosic sludge through biodrying: Aeration strategies, quality of end-products, gaseous emissions and techno-economic assessment. Waste Manag 2021; 126:487-496. [PMID: 33838388 DOI: 10.1016/j.wasman.2021.03.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/27/2020] [Revised: 03/22/2021] [Accepted: 03/23/2021] [Indexed: 06/12/2023]
Abstract
This study assesses the technological, environmental and economic feasibility of biodrying to valorise cellulosic sludge as a renewable energy source. Specifically, three different aeration strategies were compared in terms of biodrying performance, energetic consumption, gaseous emissions, quality of end-products and techno-economic analysis. These strategies were based on different combinations of convective drying with biogenic heat produced. Two innovative biodrying performance indicators (Energetic Biodrying Index and Biodrying Performance Index) were proposed to better assess the initial and operational conditions that favour the maximum energy process efficiency and the highest end-product quality. The end-products obtained consistently presented moisture contents below 40% and lower heating values above 9.4 MJ·kg-1. However, the best values achieved were 32.6% and 10.4 MJ·kg-1 for moisture content and lower heating value, respectively. Low N2O and CH4 emissions confirmed the effective aeration of all three strategies carried out, while NH4 and tVOCs were related either to temperature or biological phenomena. A techno-economic analysis proved the economic viability and attractiveness of the biodrying technology for cellulosic sludge in all the strategies applied.
Collapse
Affiliation(s)
- N Guerra-Gorostegi
- BETA Technological Center, Science and Technology Faculty, University of Vic-Central University of Catalonia, 08500 Vic, Barcelona, Spain
| | - D González
- Composting Research Group (GICOM), Dept. of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain; Group of Biological Treatment of Liquid and Gaseous Effluents (GENOCOV), Dept. of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
| | - B Puyuelo
- BETA Technological Center, Science and Technology Faculty, University of Vic-Central University of Catalonia, 08500 Vic, Barcelona, Spain
| | - J Ovejero
- BETA Technological Center, Science and Technology Faculty, University of Vic-Central University of Catalonia, 08500 Vic, Barcelona, Spain
| | - J Colón
- BETA Technological Center, Science and Technology Faculty, University of Vic-Central University of Catalonia, 08500 Vic, Barcelona, Spain
| | - D Gabriel
- Group of Biological Treatment of Liquid and Gaseous Effluents (GENOCOV), Dept. of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
| | - A Sánchez
- Composting Research Group (GICOM), Dept. of Chemical, Biological and Environmental Engineering, Universitat Autònoma de Barcelona, 08193 Bellaterra, Barcelona, Spain
| | - S Ponsá
- BETA Technological Center, Science and Technology Faculty, University of Vic-Central University of Catalonia, 08500 Vic, Barcelona, Spain.
| |
Collapse
|
26
|
Brance ML, Pons-Estel BA, Quagliato NJ, Jorfen M, Berbotto G, Cortese N, Raggio JC, Palatnik M, Chavero I, Soldano J, Dieguez C, Sánchez A, Del Rio L, Di Gregorio S, Brun LR. Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling. Osteoporos Int 2021; 32:705-714. [PMID: 32974730 DOI: 10.1007/s00198-020-05641-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/17/2020] [Accepted: 09/15/2020] [Indexed: 10/23/2022]
Abstract
UNLABELLED Rheumatoid arthritis (RA) patients had a higher risk of developing low bone mineral density (BMD) or osteoporosis. RA patients on classic disease-modifying antirheumatic drug (c-DMARD) therapy showed significantly lower BMD than controls, while no significant differences in most parameters were found between RA patients receiving biological disease-modifying antirheumatic drugs (b-DMARDs) and controls. The 3D analysis allowed us to find changes in the trabecular and cortical compartments. INTRODUCTION To evaluate cortical and trabecular bone involvement of the hip in RA patients by dual-energy X-ray absorptiometry (DXA) and 3D analysis. The secondary end-point was to evaluate bone involvement in patients treated with classic (c-DMARD) or biological (b-DMARD) disease-modifying antirheumatic drug therapies and the effect of the duration of the disease and corticosteroid therapy on 3D parameters. METHODS A cross-sectional study of 105 RA patients and 100 subjects as a control group (CG) matched by age, sex, and BMI was carried out. BMD was measured by DXA of the bilateral femoral neck (FN) and total hip (TH). The 3D analyses including trabecular and cortical BMD were performed on hip scans with the 3D-Shaper software. RESULTS FN and TH BMD and trabecular and cortical vBMD were significantly lower in RA patients. The c-DMARD (n = 75) group showed significantly lower trabecular and cortical vBMD than the CG. Despite the lower values, the b-DMARD group (n = 30) showed no significant differences in most parameters compared with the CG. The trabecular and cortical 3D parameters were significantly lower in the group with an RA disease duration of 1 to 5 years than in the CG, and the trabecular vBMD was significantly lower in the group with a duration of corticosteroid therapy of 1 to 5 years than in the CG, while no significant differences were found by standard DXA in the same period. CONCLUSIONS RA patients had a higher risk of developing low BMD or osteoporosis than controls. RA patients receiving c-DMARD therapy showed significantly lower BMD than controls, while no significant differences in most parameters were found between RA patients receiving b-DMARDs and controls. 3D-DXA allowed us to find changes in trabecular and cortical bone compartments in RA patients.
Collapse
Affiliation(s)
- M L Brance
- Reumatología y Enfermedades Óseas, Rosario, Argentina
- Bone Biology Laboratory, School of Medicine, Rosario National University, Rosario, Argentina
- National Council of Scientific and Technical Research (CONICET), Buenos Aires, Argentina
| | - B A Pons-Estel
- Centro Regional de Enfermedades Autoinmunes y Reumáticas (GO-CREAR), Rosario, Argentina
| | | | - M Jorfen
- Reumatología y Enfermedades Óseas, Rosario, Argentina
| | - G Berbotto
- Reumatología y Enfermedades Óseas, Rosario, Argentina
| | - N Cortese
- School of Medicine, Rosario National University, Rosario, Argentina
| | - J C Raggio
- Reumatología y Enfermedades Óseas, Rosario, Argentina
| | - M Palatnik
- Centro de Reumatología, Rosario, Argentina
| | - I Chavero
- Reumatología y Enfermedades Óseas, Rosario, Argentina
| | - J Soldano
- School of Medicine, Rosario National University, Rosario, Argentina
| | - C Dieguez
- Reumatología y Enfermedades Óseas, Rosario, Argentina
| | - A Sánchez
- Centro de Endocrinología, Rosario, Argentina
| | | | | | - L R Brun
- Bone Biology Laboratory, School of Medicine, Rosario National University, Rosario, Argentina.
- National Council of Scientific and Technical Research (CONICET), Buenos Aires, Argentina.
| |
Collapse
|
27
|
Mera A, Ruiz-Rodriguez JC, Sánchez A, Ferrer R. Emphysematous cystitis. An unusual cause of septic shock. Med Intensiva 2021; 47:S0210-5691(21)00008-5. [PMID: 33674125 DOI: 10.1016/j.medin.2021.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2021] [Accepted: 01/25/2021] [Indexed: 10/22/2022]
Affiliation(s)
- A Mera
- Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain.
| | - J C Ruiz-Rodriguez
- Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain
| | - A Sánchez
- Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain
| | - R Ferrer
- Intensive Care Medicine Department, Vall d'Hebron University Hospital, Barcelona, Spain
| |
Collapse
|
28
|
Rivera A, Sánchez A, Luque S, Mur I, Puig L, Crusi X, González JC, Sorlí L, González A, Horcajada JP, Navarro F, Benito N. Intraoperative Bacterial Contamination and Activity of Different Antimicrobial Prophylaxis Regimens in Primary Knee and Hip Replacement. Antibiotics (Basel) 2020; 10:antibiotics10010018. [PMID: 33375415 PMCID: PMC7823842 DOI: 10.3390/antibiotics10010018] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2020] [Revised: 12/22/2020] [Accepted: 12/23/2020] [Indexed: 02/05/2023] Open
Abstract
Surgical antimicrobial prophylaxis (SAP) is important for the prevention of prosthetic joint infections (PJIs) and must be effective against the microorganisms most likely to contaminate the surgical site. Our aim was to compare different SAP regimens (cefazolin, cefuroxime, or vancomycin, alone or combined with gentamicin) in patients undergoing total knee (TKA) and hip (THA) arthroplasty. In this preclinical exploratory analysis, we analyzed the results of intraoperative sample cultures, the ratio of plasma antibiotic levels to the minimum inhibitory concentrations (MICs) for bacteria isolated at the surgical wound and ATCC strains, and serum bactericidal titers (SBT) against the same microorganisms. A total of 132 surgical procedures (68 TKA, 64 THA) in 128 patients were included. Cultures were positive in 57 (43.2%) procedures (mostly for coagulase-negative staphylococci and Cutibacterium spp.); the rate was lower in the group of patients receiving combination SAP (adjusted OR 0.475, CI95% 0.229-0.987). The SAP regimens evaluated achieved plasma levels above the MICs in almost all of intraoperative isolates (93/94, 98.9%) and showed bactericidal activity against all of them (SBT range 1:8-1:1024), although SBTs were higher in patients receiving cefazolin and gentamicin-containing regimens. The potential clinical relevance of these findings in the prevention of PJIs remains to be determined.
Collapse
Affiliation(s)
- Alba Rivera
- Department of Microbiology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (A.R.); (A.S.); (F.N.)
- Department of Genetic and Microbiology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
| | - Alba Sánchez
- Department of Microbiology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (A.R.); (A.S.); (F.N.)
- Department of Genetic and Microbiology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
| | - Sonia Luque
- Department of Pharmacy, Hospital del Mar—Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain;
| | - Isabel Mur
- Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain; (I.M.); (J.P.H.)
- Infectious Disease Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain
- Bone and Joint Infection Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEIO-SEIMC), 28003 Madrid, Spain;
| | - Lluís Puig
- Department of Orthopedic Surgery and Traumatology, Hospital del Mar—Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain;
| | - Xavier Crusi
- Department of Orthopedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (X.C.); (J.C.G.); (A.G.)
| | - José Carlos González
- Department of Orthopedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (X.C.); (J.C.G.); (A.G.)
| | - Luisa Sorlí
- Bone and Joint Infection Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEIO-SEIMC), 28003 Madrid, Spain;
- Department of Infectious Diseases, Hospital del Mar—Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
- Department of Experimental and Health Sciences, Universitat Pompeu Fabra, 08003 Barcelona, Spain
| | - Aránzazu González
- Department of Orthopedic Surgery and Traumatology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (X.C.); (J.C.G.); (A.G.)
| | - Juan Pablo Horcajada
- Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain; (I.M.); (J.P.H.)
- Department of Infectious Diseases, Hospital del Mar—Hospital del Mar Medical Research Institute (IMIM), 08003 Barcelona, Spain
| | - Ferran Navarro
- Department of Microbiology, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain; (A.R.); (A.S.); (F.N.)
- Department of Genetic and Microbiology, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain
| | - Natividad Benito
- Department of Medicine, Faculty of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain; (I.M.); (J.P.H.)
- Infectious Disease Unit, Department of Internal Medicine, Hospital de la Santa Creu i Sant Pau—Institut d’Investigació Biomèdica Sant Pau, 08025 Barcelona, Spain
- Bone and Joint Infection Study Group of the Spanish Society of Infectious Diseases and Clinical Microbiology (GEIO-SEIMC), 28003 Madrid, Spain;
- Correspondence:
| |
Collapse
|
29
|
Ablondi M, Gòdia M, Rodriguez-Gil JE, Sánchez A, Clop A. Characterisation of sperm piRNAs and their correlation with semen quality traits in swine. Anim Genet 2020; 52:114-120. [PMID: 33226164 DOI: 10.1111/age.13022] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/13/2020] [Indexed: 12/17/2022]
Abstract
Piwi-interacting RNAs (piRNAs) are a class of non-coding RNAs that are essential in the transcriptional silencing of transposable elements and warrant genome stability in the mammalian germline. In this study, we have identified piRNAs in porcine sperm using male germline and zygote datasets from human, mice, cow and pig, and evaluated the relation between their abundances and sperm quality traits. In our analysis, we identified 283 382 piRNAs, 1355 of which correlated with P ≤ 0.01 to at least one semen quality trait. Fifty-seven percent of the correlated piRNAs mapped less than 50 kb apart from any other piRNA in the pig genome. Furthermore, piRNA location was significantly enriched near long interspersed nuclear elements. Moreover, some of the significant piRNAs mapped within or close to genes relevant for fertility or spermatogenesis such as CSNK1G2 and PSMF1.
Collapse
Affiliation(s)
- M Ablondi
- Department of Veterinary Science, University of Parma, Parma, 43126, Italy
| | - M Gòdia
- Centre for Research in Agricultural Genomics,, CSIC-IRTA-UAB-UB, Campus UAB, Cerdanyola del Vallès, Catalonia, 08193, Spain
| | - J E Rodriguez-Gil
- Department of Animal Medicine and Surgery, School of Veterinary Sciences, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalonia, 08193, Spain
| | - A Sánchez
- Centre for Research in Agricultural Genomics,, CSIC-IRTA-UAB-UB, Campus UAB, Cerdanyola del Vallès, Catalonia, 08193, Spain.,Departament de Ciència Animal i dels Aliments, School of Veterinary Sciences, Universitat Autonoma de Barcelona, Cerdanyola del Vallès, Catalonia, 08193, Spain
| | - A Clop
- Centre for Research in Agricultural Genomics,, CSIC-IRTA-UAB-UB, Campus UAB, Cerdanyola del Vallès, Catalonia, 08193, Spain.,Consejo Superior de Investigaciones Científicas, Barcelona, Catalonia, 08003, Spain
| |
Collapse
|
30
|
Arroyo M, Cañuelo A, Calahorra J, Hastert F, Sánchez A, Clarke DJ, Marchal J. Mitotic entry upon Topo II catalytic inhibition is controlled by Chk1 and Plk1. FEBS J 2020; 287:4933-4951. [PMID: 32144855 PMCID: PMC7483426 DOI: 10.1111/febs.15280] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2019] [Revised: 01/13/2020] [Accepted: 03/03/2020] [Indexed: 12/11/2022]
Abstract
Catalytic inhibition of topoisomerase II during G2 phase delays onset of mitosis due to the activation of the so-called decatenation checkpoint. This checkpoint is less known compared with the extensively studied G2 DNA damage checkpoint and is partially compromised in many tumor cells. We recently identified MCPH1 as a key regulator that confers cells with the capacity to adapt to the decatenation checkpoint. In the present work, we have explored the contributions of checkpoint kinase 1 (Chk1) and polo-like kinase 1 (Plk1), in order to better understand the molecular basis of decatenation checkpoint. Our results demonstrate that Chk1 function is required to sustain the G2 arrest induced by catalytic inhibition of Topo II. Interestingly, Chk1 loss of function restores adaptation in cells lacking MCPH1. Furthermore, we demonstrate that Plk1 function is required to bypass the decatenation checkpoint arrest in cells following Chk1 inhibition. Taken together, our data suggest that MCPH1 is critical to allow checkpoint adaptation by counteracting Chk1-mediated inactivation of Plk1. Importantly, we also provide evidence that MCPH1 function is not required to allow recovery from this checkpoint, which lends support to the notion that checkpoint adaptation and recovery are different mechanisms distinguished in part by specific effectors.
Collapse
Affiliation(s)
- M. Arroyo
- Departamento de Biología ExperimentalUniversidad de Jaén, Spain
| | - A. Cañuelo
- Departamento de Biología ExperimentalUniversidad de Jaén, Spain
| | - J. Calahorra
- Departamento de Biología ExperimentalUniversidad de Jaén, Spain
| | - F.D. Hastert
- Department of Biology, Technische Universität Darmstadt, Germany
| | - A. Sánchez
- Departamento de Biología ExperimentalUniversidad de Jaén, Spain
| | - D. J. Clarke
- Department of Genetics, Cell Biology and Development, University of Minnesota, US
| | - J.A. Marchal
- Departamento de Biología ExperimentalUniversidad de Jaén, Spain
| |
Collapse
|
31
|
Cámara A, Compta Y, Pérez-Soriano A, Montagut N, Ahuir M, Ludeña E, Baixauli M, Peri-Cusi L, Fernández N, Villote S, Caballol N, Buongiorno M, Pont-Sunyer C, Puente V, Giraldo D, Garrido A, Painous C, Sánchez A, Muñoz E, Valldeoriola F, Lombraña M, Martí M. Healthcare education program in multiple system atrophy - preliminary results of satisfaction from a national registry based longitudinal study. Parkinsonism Relat Disord 2020. [DOI: 10.1016/j.parkreldis.2020.06.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Sánchez JP, Legarra A, Velasco-Galilea M, Piles M, Sánchez A, Rafel O, González-Rodríguez O, Ballester M. Genome-wide association study for feed efficiency in collective cage-raised rabbits under full and restricted feeding. Anim Genet 2020; 51:799-810. [PMID: 32697387 PMCID: PMC7540659 DOI: 10.1111/age.12988] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2019] [Revised: 06/16/2020] [Accepted: 06/26/2020] [Indexed: 01/30/2023]
Abstract
Feed efficiency (FE) is one of the most economically and environmentally relevant traits in the animal production sector. The objective of this study was to gain knowledge about the genetic control of FE in rabbits. To this end, GWASs were conducted for individual growth under two feeding regimes (full feeding and restricted) and FE traits collected from cage groups, using 114 604 autosome SNPs segregating in 438 rabbits. Two different models were implemented: (1) an animal model with a linear regression on each SNP allele for growth trait; and (2) a two‐trait animal model, jointly fitting the performance trait and each SNP allele content, for FE traits. This last modeling strategy is a new tool applied to GWAS and allows information to be considered from non‐genotyped individuals whose contribution is relevant in the group average traits. A total of 189 SNPs in 17 chromosomal regions were declared to be significantly associated with any of the five analyzed traits at a chromosome‐wide level. In 12 of these regions, 20 candidate genes were proposed to explain the variation of the analyzed traits, including genes such as FTO, NDUFAF6 and CEBPA previously associated with growth and FE traits in monogastric species. Candidate genes associated with behavioral patterns were also identified. Overall, our results can be considered as the foundation for future functional research to unravel the actual causal mutations regulating growth and FE in rabbits.
Collapse
Affiliation(s)
- J P Sánchez
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| | - A Legarra
- GenPhySE, National Institute for Agronomic Research, Castanet-Tolosan, 31326, France
| | - M Velasco-Galilea
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| | - M Piles
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| | - A Sánchez
- Centre for Research in Agricultural Genomics, Campus Universitat Autònoma de Barcelona, Cerdanyola, 08193, Spain
| | - O Rafel
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| | - O González-Rodríguez
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| | - M Ballester
- Animal Breeding and Genetic Program, Institute of Agriculture and Food Research and Technology, Caldes de Montbui, 08140, Spain
| |
Collapse
|
33
|
García-Galán A, De la Fe C, Gomis J, Bataller E, Sánchez A, Quereda JJ, García-Roselló E, Gómez-Martín A. The addition of Lactobacillus spp. negatively affects Mycoplasma bovis viability in bovine cervical mucus. BMC Vet Res 2020; 16:251. [PMID: 32690006 PMCID: PMC7370443 DOI: 10.1186/s12917-020-02454-9] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2020] [Accepted: 07/03/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Mycoplasma bovis is an important pathogen for the cattle industry worldwide causing significant economic losses. Several transmission routes, including those related to reproduction, have been described. Indeed, the pathogen can colonize the female reproductive tract after artificial insemination (AI) with contaminated semen. Lactobacillus spp.-based probiotics have been used for vaginal dysbiosis treatment in women and cows although their role in controlling cervico-vaginal infections due to M. bovis is unknown. The objective of the present work is to assess the viability of M. bovis (PG45, NCTC 10131) in experimentally contaminated cervical mucus after the addition of Lactobacillus spp. at different concentrations as a competing agent and pH acidifier. RESULTS The addition of probiotic at a concentration higher than 108 colony forming units (CFU/mL had a detrimental effect (P < 0.05) on mycoplasma viability in cervical mucus. This coincided with a significant LAB growth and an important decrease in pH from 8.4 to 5.6 (P < 0.05). However, after the addition of less concentrated probiotic, M. bovis survival was not affected and there was no significant LAB growth despite the drop of pH from 8.4 to 6.73 (P < 0.05). CONCLUSION The addition of concentrations higher than 108 CFU/mL of Lactobacillus spp. negatively affects M. bovis viability in bovine cervical mucus under in vitro conditions. Although the effect observed on the pathogen viability seems to be related to the pH decrease after LAB proliferation in cervical mucus, further studies are necessary to elucidate if other factors are implicated. Nevertheless, the administration of Lactobacillus spp.-based probiotics might be used in the future to control M. bovis proliferation in the cervico-vaginal tract of cows.
Collapse
Affiliation(s)
- A García-Galán
- Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30100, Murcia, Spain
| | - C De la Fe
- Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30100, Murcia, Spain.
| | - J Gomis
- Microbiological Agents Associated with Reproduction (ProVaginBio) Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 46113, Valencia, Spain
| | - E Bataller
- Microbiological Agents Associated with Reproduction (ProVaginBio) Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 46113, Valencia, Spain
| | - A Sánchez
- Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30100, Murcia, Spain
| | - J J Quereda
- Microbiological Agents Associated with Reproduction (ProVaginBio) Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 46113, Valencia, Spain
| | - E García-Roselló
- Microbiological Agents Associated with Reproduction (ProVaginBio) Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 46113, Valencia, Spain
| | - A Gómez-Martín
- Ruminant Health Research Group, Department of Animal Health, Faculty of Veterinary Sciences, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, 30100, Murcia, Spain.,Microbiological Agents Associated with Reproduction (ProVaginBio) Research Group, Universidad Cardenal Herrera-CEU, CEU Universities, 46113, Valencia, Spain
| |
Collapse
|
34
|
Sánchez A, Perea J, Montenegro L, Espinoza I, Avellaneda J, Barba C. Cinética de degradación ruminal in situ de ensilado de rastrojo de maíz (Zea mays) con niveles crecientes de urea. ARCH ZOOTEC 2020. [DOI: 10.21071/az.v69i267.5351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
Abstract
Se estudió el efecto de la inclusión de urea sobre la composición y cinética de degradación ruminal in situ en el ensilado de rastrojo de maíz. Se partió de cuatro de tratamientos al adicionar el 0, 1, 2 y 3% de urea a una mezcla de rastrojo de maíz con el 10% de melaza. Se elaboraron 128 microsilos (3 kg/unidad y 4 repeticiones por tratamiento). La apertura de los silos se realizó a los 7, 14, 21, 28, 35, 42, 49 y 56 días. Se determinó el contenido de la materia seca (MS), materia orgánica (MO), proteína bruta (PB), FND y FAD. La degradabilidad in situ se obtuvo mediante el método de Mehrez y Orskov y la degradabilidad de MS y PB mediante el análisis de los residuos con el método Kjeldhal. Los datos se analizaron con el procedimiento GLM y el test de Tukey (P±
Collapse
|
35
|
Martinez NW, Sánchez A, Diaz P, Broekhuizen R, Godoy J, Mondaca S, Catenaccio A, Macanas P, Nervi B, Calvo M, Court FA. Metformin protects from oxaliplatin induced peripheral neuropathy in rats. Neurobiol Pain 2020; 8:100048. [PMID: 32490289 PMCID: PMC7260677 DOI: 10.1016/j.ynpai.2020.100048] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Revised: 04/20/2020] [Accepted: 05/12/2020] [Indexed: 12/14/2022]
Abstract
After oxaliplatin treatment rats developed mechanical and cold hyperalgesia. We observed intraepidermal nerve fiber degeneration, and mild spinal cord gliosis. Co treatment with Metformin could prevent all these pathological outcomes. This suggests metformin as a candidate drug to prevent oxaliplatin-induced neuropathy.
Oxaliplatin is a commonly used drug to treat cancer, extending the rate of disease-free survival by 20% in colorectal cancer. However, oxaliplatin induces a disabling form of neuropathy resulting in more than 60% of patients having to reduce or discontinue oxaliplatin, negatively impacting their chance of survival. Oxaliplatin-induced neuropathies are accompanied by degeneration of sensory fibers in the epidermis and hyperexcitability of sensory neurons. These morphological and functional changes have been associated with sensory symptoms such as dysesthesia, paresthesia and mechanical and cold allodynia. Various strategies have been proposed to prevent or treat oxaliplatin-induced neuropathies without success. The anti-diabetic drug metformin has been recently shown to exert neuroprotection in other chemotherapy-induced neuropathies, so here we aimed to test if metformin can prevent the development of oxaliplatin-induced neuropathy in a rat model of this condition. Animals treated with oxaliplatin developed significant intraepidermal fiber degeneration, a mild gliosis in the spinal cord, and mechanical and cold hyperalgesia. The concomitant use of metformin prevented degeneration of intraepidermal fibers, gliosis, and the altered sensitivity. Our evidence further supports metformin as a new approach to prevent oxaliplatin-induced neuropathy with a potential important clinical impact.
Collapse
Affiliation(s)
- N W Martinez
- Center for Integrative Biology, Faculty of Sciences, Universidad Mayor de Chile, Santiago 8580745, Chile.,Department of Physiology, Faculty of Biology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - A Sánchez
- Department of Physiology, Faculty of Biology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - P Diaz
- Department of Physiology, Faculty of Biology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - R Broekhuizen
- Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - J Godoy
- Department of Neurology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - S Mondaca
- Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - A Catenaccio
- Center for Integrative Biology, Faculty of Sciences, Universidad Mayor de Chile, Santiago 8580745, Chile
| | - P Macanas
- Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - B Nervi
- Department of Hematology and Oncology, Pontificia Universidad Católica de Chile, Santiago, Chile.,Millennium Institute on Immunology and Immunotherapy, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - M Calvo
- Department of Physiology, Faculty of Biology, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - F A Court
- Center for Integrative Biology, Faculty of Sciences, Universidad Mayor de Chile, Santiago 8580745, Chile.,FONDAP Center for Geroscience, Brain Health and Metabolism, Santiago 8580745, Chile.,Buck Institute for Research on Ageing, Novato, San Francisco, CA 94945, USA
| |
Collapse
|
36
|
Sánchez A, Benito N, Rivera A, García L, Miró E, Mur I, González Y, Gutiérrez C, Horcajada JP, Espinal P, Navarro F. Pathogenesis of Staphylococcus epidermidis in prosthetic joint infections: Can identification of virulence genes differentiate between infecting and commensal strains? J Hosp Infect 2020; 105:S0195-6701(20)30201-2. [PMID: 32339618 DOI: 10.1016/j.jhin.2020.04.026] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/20/2020] [Accepted: 04/17/2020] [Indexed: 02/08/2023]
Abstract
BACKGROUND Staphylococcus epidermidis is a commensal of human skin flora and a frequent causative microorganism in prosthetic joint infections (PJIs). To date, no single marker has been identified to distinguish infecting strains from commensal S. epidermidis populations. AIM We aimed to find possible genetic markers to distinguish between the two populations. METHODS We analyzed 50 S. epidermidis strains from patients with PJIs, 50 from skin of healthy individuals (commensal strains) and 17 from the surgical field of patients undergoing primary arthroplasty. In these three groups we studied the antimicrobial susceptibility profile, sequence type, biofilm formation, and virulence factors. Strains from the surgical field have not been compared previously with strains from the other two groups. FINDINGS S. epidermidis strains from PJI patients were significantly more antibiotic resistant than commensal strains and surgical field strains. A wide variety of sequences types was found in commensal and surgical field strains. The predominant sequence type was ST2 and it was only present in PJI strains (44%). Differences in biofilm production did not differ between populations. Virulence genes sdrF and bhp, the complete ica operon, and the insertion sequence IS256 were significantly predominant in PJI strains. In contrast, embp and hld genes and the mobile element ACME were more prevalent in commensal strains. Surgical field strains could be a valid control group to discriminate between infecting and commensal strains. CONCLUSION A combination of characteristic features can differentiate between infecting and commensal S. epidermidis strains in PJI, while a single marker cannot.
Collapse
Affiliation(s)
- Alba Sánchez
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain; Genetics and Microbiology Department. Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Natividad Benito
- Infectious Diseases Unit, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Alba Rivera
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
| | - Lucas García
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
| | - Elisenda Miró
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
| | - Isabel Mur
- Infectious Diseases Unit, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - Yesica González
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
| | - Cristina Gutiérrez
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain
| | | | - Paula Espinal
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain.
| | - Ferran Navarro
- Department of Microbiology, Hospital de La Santa Creu I Sant Pau, Institut D'Investigació Biomèdica Sant Pau (IIB Sant Pau), Barcelona, Spain; Genetics and Microbiology Department. Universitat Autònoma de Barcelona, Barcelona, Spain.
| |
Collapse
|
37
|
Castanon Alvarez E, Vidal C, Resano L, Sánchez A, Rodriguez M, Salas D, Fernandez de Sanmamed M, López Picazo J, Sanchez L, Espinos J, Melero I, Gonzalez A, Ponz-Sarvisé M. 14P Comparison of the predictive power of survival of the Royal Marsden Score, the GRIM score and the LIPI score in phase I trial patients. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.01.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
38
|
Vicente-Pascual M, Montejo C, Sánchez A, Llull L. The relevance of anhidrosis in Horner syndrome: analysis of an image. Neurología (English Edition) 2020. [DOI: 10.1016/j.nrleng.2017.10.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
|
39
|
Vicente-Pascual M, Montejo C, Sánchez A, Llull L. La relevancia de la anhidrosis en el síndrome de Horner. A propósito de una imagen. Neurologia 2020; 35:132-134. [DOI: 10.1016/j.nrl.2017.10.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2017] [Accepted: 10/16/2017] [Indexed: 10/18/2022] Open
|
40
|
Montejo C, Vicente M, Sánchez A, Renú A. Basilar artery thrombosis caused by vertebral dissection secondary to brachial plexus block. Neurología (English Edition) 2020. [DOI: 10.1016/j.nrleng.2017.06.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
41
|
Mansfield AS, Każarnowicz A, Karaseva N, Sánchez A, De Boer R, Andric Z, Reck M, Atagi S, Lee JS, Garassino M, Liu SV, Horn L, Wen X, Quach C, Yu W, Kabbinavar F, Lam S, Morris S, Califano R. Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial. Ann Oncol 2019; 31:310-317. [PMID: 31959349 DOI: 10.1016/j.annonc.2019.10.021] [Citation(s) in RCA: 93] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2019] [Revised: 09/27/2019] [Accepted: 10/20/2019] [Indexed: 12/16/2022] Open
Abstract
BACKGROUND The addition of atezolizumab to carboplatin and etoposide (CP/ET) significantly improved progression-free and overall survival for patients with extensive-stage small-cell lung cancer (ES-SCLC) in the IMpower133 study (NCT02763579). We have evaluated adverse events (AEs) and patient-reported outcomes in IMpower133 to assess the benefit-risk profile of this regimen. PATIENTS AND METHODS Patients received four 21-day cycles of CP/ET plus intravenous atezolizumab 1200 mg or placebo (induction phase), followed by atezolizumab or placebo (maintenance phase) until progression or loss of benefit. AEs were assessed and patient-reported outcomes were evaluated every 3 weeks during treatment using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 (QLQ-C30) and QLQ-LC13. RESULTS Overall, 394 patients were assessable for safety in the induction phase and 318 in the maintenance phase. The frequency of AEs, grade 3-4 AEs, and serious AEs was similar between arms in both phases. Immune-related AEs were more frequent in the atezolizumab arm during both induction (28% versus 17%; leading to atezolizumab/placebo interruption 9% versus 5%, leading to withdrawal 4% versus 0%) and maintenance (26% versus 15%; leading to atezolizumab/placebo interruption, 3% versus 2%, leading to withdrawal 1% versus 1%), most commonly rash (induction 11% versus 9%, maintenance 14% versus 4%), and hypothyroidism (induction 4.0% versus 0%, maintenance 10% versus 1%). Changes in patient-reported treatment-related symptoms commonly associated with quality of life impairment were generally similar during induction and most of the maintenance phase. Patient-reported function and health-related quality of life (HRQoL) improved in both arms after initiating treatment, with more pronounced and persistent HRQoL improvements in the atezolizumab arm. CONCLUSIONS In patients with ES-SCLC, atezolizumab plus CP/ET has a comparable safety profile to placebo plus CP/ET, and the addition of atezolizumab did not adversely impact patient-reported HRQoL. These data demonstrate the positive benefit-risk profile of first-line atezolizumab plus CP/ET in ES-SCLC and further support this regimen as a new standard of care in this setting. CLINICAL TRIALS NUMBER NCT02763579.
Collapse
Affiliation(s)
- A S Mansfield
- Division of Medical Oncology, Mayo Clinic, Rochester, USA.
| | - A Każarnowicz
- Department of Oncology, Tuberculosis and Lung Disease Hospital, Olsztyn, Poland
| | - N Karaseva
- City Clinical Oncology Dispensary, St Petersburg, Russia
| | - A Sánchez
- Department of Medical Oncology, Hospital Universitario "Virgen del Rocio", Seville, Spain
| | - R De Boer
- Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
| | - Z Andric
- Department of Medical Oncology, University Hospital Medical Center Bezanijska Kosa, Belgrade, Serbia
| | - M Reck
- Department of Thoracic Oncology, German Center for Lung Research (DZL), Großhansdorf, Germany
| | - S Atagi
- Department of Thoracic Oncology, Kinki-Chuo Chest Medical Center, Osaka, Japan
| | - J-S Lee
- Division of Hematology-Oncology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
| | - M Garassino
- Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
| | - S V Liu
- Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC, USA
| | - L Horn
- Thoracic Oncology Program, Vanderbilt University Medical Center, Nashville, USA
| | - X Wen
- Product Development Oncology, Genentech, Inc., South San Francisco, USA
| | - C Quach
- Product Development Oncology, Genentech, Inc., South San Francisco, USA
| | - W Yu
- Biometrics, Genentech, Inc., South San Francisco, USA
| | - F Kabbinavar
- Product Development Oncology, Genentech, Inc., South San Francisco, USA
| | - S Lam
- Product Development Oncology, Genentech, Inc., South San Francisco, USA
| | - S Morris
- Global PD Medical Affairs (Oncology), F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - R Califano
- Department of Medical Oncology, The Christie NHS Foundation Trust, and Division of Cancer Sciences, University of Manchester, Manchester, UK
| |
Collapse
|
42
|
Sánchez L, Pérez MD, Puyol P, Calvo M, Brett G, Cattaneo TMP, Haasnoot W, López-Fandiño R, Manso MA, Mata L, Razquín P, Sánchez A, Svenning C, Vegarud GE. Determination of Vegetal Proteins in Milk Powder by Enzyme-Linked Immunosorbent Assay: Interlaboratory Study. J AOAC Int 2019. [DOI: 10.1093/jaoac/85.6.1390] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
Abstract
Eight laboratories participated in a collaborative study to evaluate an enzyme-linked immunosorbent assay (ELISA) to determine soy, pea, and wheat proteins in pasteurized or ultra-high temperature (UHT) milk powders. To perform this assay, polyclonal antibodies for soy, pea, and wheat proteins were obtained from rabbit sera. Collaborators received calibration standards composed of milk powder containing 0–8% (w/w) vegetal protein in total protein and blind test samples containing approximately 1, 2, and 5% (w/w) vegetal protein. An indirect competitive ELISA was performed with a kit prepared by a participating laboratory; the kit contained plates coated with soy, pea, or wheat proteins, the corresponding specific antisera, enzyme-labeled second antibody, and substrate solution. Test samples and calibrants were extracted with phosphate-buffered saline, pH 7.4, containing 0.05% Tween and assayed with the ELISA kits. The degree of adulteration was affected by the type of heat treatment applied to the samples. The estimated percentage of vegetal protein addition was close to the theoretical value for pasteurized samples but much lower for UHT samples. For pasteurized samples, intralaboratory relative standard deviations ranged from 5 to 22% and interlaboratory relative standard deviations ranged from 14 to 34%.
Collapse
Affiliation(s)
- Lourdes Sánchez
- Tecnología de los Alimentos, Facultad de Veterinaria, Miguel Servet, 177, 50013-Zaragoza, Spain
| | - María D Pérez
- Tecnología de los Alimentos, Facultad de Veterinaria, Miguel Servet, 177, 50013-Zaragoza, Spain
| | - Pilar Puyol
- Tecnología de los Alimentos, Facultad de Veterinaria, Miguel Servet, 177, 50013-Zaragoza, Spain
| | - Miguel Calvo
- Tecnología de los Alimentos, Facultad de Veterinaria, Miguel Servet, 177, 50013-Zaragoza, Spain
| | - Gary Brett
- Institute of Food Research, Norwich Research Park, Colney, Norwich, Norfolk, NR4 7UA United Kingdom
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
García IR, Sánchez A, Ortega A, Pradera J, Cobo M, Moreno M, Barneto I, Ruiz S, Fernández I, García T, Toscano F, Perez JT. EP1.01-28 Real World Use of Afatinib in NSCLC EGFRm+ Patients Outside Clinical Trials: A FAETT Experience. J Thorac Oncol 2019. [DOI: 10.1016/j.jtho.2019.08.2001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
44
|
Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano JM, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón ML, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R, Jiménez-Fonseca P. Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry. Clin Transl Oncol 2019; 22:734-750. [PMID: 31385226 DOI: 10.1007/s12094-019-02183-y] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2019] [Accepted: 07/08/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND The optimal duration of first-line chemotherapy for patients with advanced gastric cancer is unknown. Diverse clinical trials have proposed different strategies including limited treatment, maintenance of some drugs, or treatment until progression. METHOD The sample comprises patients from the AGAMENON multicenter registry without progression after second evaluation of response. The objective was to explore the optimal duration of first-line chemotherapy. A frailty multi-state model was conducted. RESULTS 415 patients were divided into three strata: discontinuation of platinum and maintenance with fluoropyrimidine until progression (30%, n = 123), complete treatment withdrawal prior to progression (52%, n = 216), and full treatment until progression (18%, n = 76). The hazard of tumor progression decreased by 19% per month with the full treatment regimen. However, we found no evidence that fluoropyrimidine maintenance (hazard ratio [HR] 1.07, confidence interval [CI] 95%, 0.69-1.65) worsened progression-free survival (PFS) with respect to treatment until progression. Predictive factors for PFS were ECOG performance status, ≥ 3 metastatic sites, prior tumor response, and bone metastases. Toxicity grade 3/4 was more common in those who continued the full treatment until progression vs fluoropyrimidine maintenance (16% vs 6%). CONCLUSION The longer duration of the full initial regimen exerted a protective effect on the patients of this registry. Platinum discontinuation followed by fluoropyrimidine maintenance yields comparable efficacy to treatment up to PD, with a lower rate of serious adverse events.
Collapse
Affiliation(s)
- A Viúdez
- Medical Oncology Department, Complejo Hospitalario de Navarra (CHN), OncobionaTras Unit, Navarrabiomed, Navarrabiomed Biomedical Center, IdiSNA, Irunlarrea 3, 31008, Pamplona, Navarra, Spain.
| | - A Carmona-Bayonas
- Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, University of Murcia, IMIB, Murcia, Spain
| | - J Gallego
- Medical Oncology Department, Hospital Universitario de Elche, Elche, Spain
| | - A Lacalle
- Medical Oncology Department, Complejo Hospitalario de Navarra, Pamplona, Spain
| | - R Hernández
- Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain
| | - J M Cano
- Medical Oncology Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain
| | - I Macías
- Medical Oncology Department, Hospital Universitario Parc Tauli, Sabadell, Spain
| | - A Custodio
- Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain
| | - E Martínez de Castro
- Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, Santander, Spain
| | - A Sánchez
- Medical Oncology Department, Hospital Universitario Doce de Octubre, Madrid, Spain
| | - L Iglesia
- Medical Oncology Department, Complejo Hospitalario de Orense, Orense, Spain
| | - P Reguera
- Medical Oncology Department, Hospital Universitario Ramón Y Cajal, Madrid, Spain
| | - L Visa
- Medical Oncology Department, Hospital Universitario El Mar, Barcelona, Spain
| | - A Azkarate
- Medical Oncology Department, Hospital Universitario Son Espases, Mallorca, Spain
| | - M Sánchez-Cánovas
- Hematology and Medical Oncology Department, Hospital Universitario Morales Meseguer, Murcia, Spain
| | - M Mangas
- Medical Oncology Department, Hospital Galdakao-Usansolo, Galdakao-Usansolo, Spain
| | - M L Limón
- Medical Oncology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain
| | - A Martínez-Torrón
- Pharmacy Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | - E Asensio
- Medical Oncology Department, Hospital Universitario de Elche, Elche, Spain
| | - A Ramchandani
- Medical Oncology Department, Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria, Spain
| | - A Martín-Carnicero
- Medical Oncology Department, Complejo Hospitalario San Millán, Logroño, Spain
| | - A Hurtado
- Medical Oncology Department, Hospital Universitario Fundación Alcorcón, Madrid, Spain
| | - P Cerdà
- Medical Oncology Department, Centro Médico Tecknon, Barcelona, Spain
| | - M Garrido
- Medical Oncology Department, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile
| | - R Sánchez-Bayonas
- Medical Oncology Department, Clínica Universidad de Navarra, Pamplona, Spain
| | - R Serrano
- Medical Oncology Department, Hospital Universitario Reina Sofía, Córdoba, Spain
| | - P Jiménez-Fonseca
- Medical Oncology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
| | | |
Collapse
|
45
|
Rodríguez P, Cerda A, Font X, Sánchez A, Artola A. Valorisation of biowaste digestate through solid state fermentation to produce biopesticides from Bacillus thuringiensis. Waste Manag 2019; 93:63-71. [PMID: 31235058 DOI: 10.1016/j.wasman.2019.05.026] [Citation(s) in RCA: 28] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/11/2019] [Revised: 05/10/2019] [Accepted: 05/15/2019] [Indexed: 06/09/2023]
Abstract
The main goal of this work is the production of a biopesticide through solid-state fermentation of biowaste digestate inoculated with Bacillus thuringiensis (Bt) at pilot scale using different configurations of reactors. Fermentations were carried out using insulated and non-insulated, stirred and non-stirred reactors at different scales (10, 22 and 100 L) in order to assess the influence of the reactor configuration on the biopesticide production process. A maximum temperature of 60 °C was reached in 10-L insulated non-stirred reactors where increments of Bt viable cells and spores with respect to initial values of 1.9 and 171.6 respectively, were attained. In contrast, when temperature was regulated by using 22-L non-insulated stirred reactors the increment of viable cells and spores were 0.8 and 1.9, respectively, at a stable temperature of 27 °C. When the non-insulated stirred reactor was scaled up to 100-L, the increase of viable cells and spore counts were 1.2 and 3.8 respectively, with an average temperature of 28 °C. These results demonstrated that the election of a proper reactor configuration is important when considering the development of a new SSF process, especially when dealing with non-conventional substrates as digestate.
Collapse
Affiliation(s)
- P Rodríguez
- Composting Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain
| | - A Cerda
- Composting Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain
| | - X Font
- Composting Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain
| | - A Sánchez
- Composting Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain.
| | - A Artola
- Composting Research Group, Department of Chemical, Biological and Environmental Engineering, Escola d'Enginyeria, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, 08193 Barcelona, Spain
| |
Collapse
|
46
|
Sánchez J, Sánchez A, Cardona R. Prevalence of Drugs as Triggers of Exacerbations in Chronic Urticaria. J Investig Allergol Clin Immunol 2019; 29:112-117. [DOI: 10.18176/jiaci.0287] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
47
|
Domingues P, Hernández-Urcera J, Cal R, Olivares A, Chimal M, Sánchez A, Rosas C, Gallardo P. Effect of triploidy on digestive enzyme activity of early stages of turbot (Scophthalmus maximus). Fish Physiol Biochem 2019; 45:573-582. [PMID: 30762186 DOI: 10.1007/s10695-019-00610-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/14/2018] [Accepted: 01/18/2019] [Indexed: 06/09/2023]
Abstract
In the present work, growth and digestive enzyme activities of total acid and alkaline proteases, pepsin, trypsin, lipase, and α-amylase, as well as partial characterization of enzyme activity, were studied in diploid and triploid turbot. Growth was similar between both groups. Acid protease activity increased consistently during the experiment, for both diploid (2n) and triploid (3n) fish. The alkaline protease activity was always higher for triploids throughout the experiment. Proteolytic acid activity (pH 2) was generally higher for diploids, at all temperatures tested. Higher activity was at pH 2 and 3 for 2n and 3n fish, respectively. Regarding temperature, acid and alkaline protease activity was higher at 37 °C and 60 °C, respectively, for both groups. The general increase in pancreatic enzymes (trypsin and amylase) before 35 days after hatching (DAH) and posterior decrease until 60 DAH. There was a marked effect on enzyme activity when changing from live prey to pellets (35 DAH), especially on triploids.
Collapse
Affiliation(s)
- P Domingues
- Instituto Español de Oceanografía (IEO), Centro Oceanográfico de Vigo, 36280, Spain
| | - J Hernández-Urcera
- Department of Ecology and Marine Resources, Marine Research Institute (CSIC), Vigo, Spain
| | - R Cal
- Instituto Español de Oceanografía (IEO), Centro Oceanográfico de Vigo, 36280, Spain
| | - A Olivares
- Facultad Ciencias del Mar y Recursos Biológicos, Universidad de Antofagasta, Antofagasta, Chile
| | - M Chimal
- Unidad Multidisciplinaria de Docencia e Investigación, Facultad de Ciencias UNAM, Puerto de Abrigo s/n, Sisal, Yucatán, Mexico
| | - A Sánchez
- Unidad Multidisciplinaria de Docencia e Investigación, Facultad de Ciencias UNAM, Puerto de Abrigo s/n, Sisal, Yucatán, Mexico
| | - C Rosas
- Unidad Multidisciplinaria de Docencia e Investigación, Facultad de Ciencias UNAM, Puerto de Abrigo s/n, Sisal, Yucatán, Mexico
| | - P Gallardo
- Unidad Multidisciplinaria de Docencia e Investigación, Facultad de Ciencias UNAM, Puerto de Abrigo s/n, Sisal, Yucatán, Mexico.
| |
Collapse
|
48
|
Ríos A, Sánchez A, López-Navas A, Martínez L, Ayala MA, Carillo J, Ruiz-Manzanera JJ, Hernández AM, Ramírez P, Parrilla P. There Is Great Ignorance About the Brain Death Concept Among the Population in Santiago de Cuba (Cuba). Transplant Proc 2019; 51:290-292. [PMID: 30879524 DOI: 10.1016/j.transproceed.2018.10.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Accepted: 10/23/2018] [Indexed: 12/31/2022]
Abstract
INTRODUCTION The knowledge of the brain death (BD) concept is important when determining the attitude toward organ donation. OBJECTIVE To analyze the level of knowledge of the BD concept among the population in Santiago de Cuba and determine the factors that condition it. METHODS From the Collaborative International Donor Project, we obtained a sample of Cubans living in the area of Santiago de Cuba (n = 455). The attitude was assessed using a validated questionnaire (PCID-DTO-RIOS). The survey was self-administered and completed anonymously. Student t test, χ2, Fisher, and logistic regression analysis were used. RESULTS Forty percent (n = 180) of the respondents know the BD concept and consider it as the death of an individual. Of the rest, 43% (n = 199) do not know about it, and the remaining 17% (n = 76) consider that it does not mean the death of a patient. The variables significantly related to the correct knowledge of BD in the multivariate analysis and considered as independent are: level of studies; the opinion of the couple toward organ donation; the religion of the respondent; having offspring; and a favorable attitude toward organ donation. CONCLUSION There is ignorance about the brain death concept among the population of Santiago de Cuba. This lack of knowledge has a direct relationship with various psychosocial factors.
Collapse
Affiliation(s)
- A Ríos
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
| | - A Sánchez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain
| | - A López-Navas
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Psychology, UCAM, San Antonio Catholic University, Murcia, Spain
| | - L Martínez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - M A Ayala
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, Mexico; Regional General Hospital No. 58 of the IMSS, Delegación Guanajuato, México; Escuela de Medicina de la Universidad de Quetzalcoatl en Irapuato, México
| | - J Carillo
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Spain
| | - J J Ruiz-Manzanera
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - A M Hernández
- Endocrinology and Nutrition Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Ramírez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Parrilla
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| |
Collapse
|
49
|
Ríos A, Sánchez A, López-Navas A, Martínez L, Ayala MA, Carillo J, Ruiz-Manzanera JJ, Hernández AM, Ramírez P, Parrilla P. Attitude Toward Organ Donation in the Population of Cienfuegos, Cuba. Transplant Proc 2019; 51:286-289. [PMID: 30879523 DOI: 10.1016/j.transproceed.2018.10.015] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Accepted: 10/23/2018] [Indexed: 12/19/2022]
Abstract
INTRODUCTION The sensitization of the population toward organ donation is fundamental; for that reason, it is important to determine the factors that condition the opinion toward donation on the population scope in order to carry out cost-effective campaigns. OBJECTIVE To analyze the attitude toward the donation of the proper organs for transplantation among the population residing in Cienfuegos, Cuba. METHOD Population under study: Population who reside in Cienfuegos, Cuba. INCLUSION CRITERIA Population over 15 years old as stratified by age and sex. Assessment instrument: The attitude questionnaire for organ donation for transplant-PCID-DTO Ríos. Fieldwork: A random selection based on stratification. The available data from the census were used. The completion was anonymous and self-administered. Verbal consent was requested to collaborate in the study. STATISTICS Student t test, χ2, Fisher, and a logistic regression analysis. RESULTS A sample of 636 respondents was included in the study, of which 71% (n = 453) are in favor of donating their organs after death, 16% (n = 103) are against, and 13% (n = 80) are undecided. This attitude is associated with different psychosocial variables (P < .001): age, marital status, having offspring, level of studies, carrying out prosocial activities, discussing with the family the subject of donation and transplantation, knowledge of the concept of brain death, the attitude toward the manipulation of the corpse, the religion of the respondent, and the attitude of the couple toward organ transplantation. The main independent factors obtained in the multivariate analysis (odds ratio >2.5): knowledge of the brain death concept, attitude toward the manipulation of the corpse, religion, and attitude of the couple toward transplantation. CONCLUSIONS The attitude toward organ donation among the population of Cienfuegos, Cuba, is favorable and is conditioned by several psychosocial factors.
Collapse
Affiliation(s)
- A Ríos
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
| | - A Sánchez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain
| | - A López-Navas
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Psychology, UCAM, San Antonio Catholic University, Murcia, Spain
| | - L Martínez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - M A Ayala
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Hospital Regional de Alta Especialidad del Bajío, León, Guanajuato, Mexico; Regional General Hospital No. 58 of the IMSS, Delegación Guanajuato, México; Escuela de Medicina de la Universidad de Quetzalcoatl en Irapuato, Irapuato, México
| | - J Carillo
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Murcia, Spain
| | - J J Ruiz-Manzanera
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - A M Hernández
- Endocrinology and Nutrition Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Ramírez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Parrilla
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia, Murcia, Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| |
Collapse
|
50
|
Ríos A, López-Gómez S, Belmonte J, López-Navas A, Sánchez A, Carrillo J, Ruiz-Manzanera JJ, Hernández AM, Ramírez P, Parrilla P. Gypsy Population Presents a Favorable Attitude Toward Related Living Donation. Transplant Proc 2019; 51:296-298. [PMID: 30879526 DOI: 10.1016/j.transproceed.2018.10.019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/15/2018] [Accepted: 10/23/2018] [Indexed: 10/28/2022]
Abstract
INTRODUCTION Negative organ donation rates among the Gypsies is much higher than that of any other social group in Spain. However, living donation rates have not been raised much in this social group, despite the existence of several Gypsy patients on the waiting list for transplantation. OBJECTIVE To analyze the attitude toward related living donation among the Gypsy population who reside in Spain. METHODS This type of study is an observational sociological study. The study consisted of the adult Gypsy population residing in Spain, and a random sampling of 230 adult gypsies was conducted. Attitude questionnaires for live donation, both hepatic PCID-DVH-Ríos and renal PCID-DVR-Ríos, were used, and random selection was based on stratification. Questionnaires were self-administered and completed anonymously. Student t test, χ2, Fisher, and a logistic regression analysis were used. RESULTS A sample of 206 Gypsies (52% women) with a mean age of 34 years is obtained. Seventy-two percent (n = 150) would donate an organ to a relative in life, 8% (n = 16) would not donate it, and 20% (n = 41) have doubts. Respondents with a favorable attitude toward living donation presented a more favorable attitude toward cadaveric organ donation (55% vs 0%, P < .001). The attitude toward living kidney donation was more favorable (81% in favor) than toward living liver donation (P < .001). CONCLUSIONS The Gypsy ethnic group is sensitized to live donor transplantation. The family and cultural roots of Gypsy people could condition this favorable attitude, a fact to be taken into account to sensitize this social group and promote donation campaigns with the aim of increasing donation rates.
Collapse
Affiliation(s)
- A Ríos
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia; Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
| | - S López-Gómez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain
| | - J Belmonte
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Servicio de Anestesia y Reanimación, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - A López-Navas
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Psychology, UCAM, San Antonio Catholic University, Murcia, Spain
| | - A Sánchez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain
| | - J Carrillo
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia; Spain
| | - J J Ruiz-Manzanera
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia; Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - A M Hernández
- Endocrinology and Nutrition Service, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Ramírez
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia; Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| | - P Parrilla
- Proyecto Colaborativo Internacional Donante (International Collaborative Donor Project), Murcia, Spain; Department of Surgery, Pediatrics, Obstetrics y Gynecology, University of Murcia; Spain; Transplant Unit, Surgery Service, IMIB-Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
| |
Collapse
|